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Posttraumatic Stress Disorder (PTSD) has been shown to be prevalent in individuals
with Substance Use Disorders (SUD). The current study aimed to investigate the factors
associated with comorbid PTSD-SUD and to identify any differences between groups of
individuals with PTSD-SUD and those with SUD only.
Methodology
Thirty participants were recruited from community services for injecting drug users. All
participants completed: The Maudsley Addiction Profile (MAP) to give measures of
physical and psychological health problems, risk of blood bome vims (BBV) infection,
and interpersonal conflict; The Leeds Dependence Questionnaire (LDQ) to measure
severity of drug dependence; and the Posttraumatic Stress Diagnostic Scale (PDS) to
determine the severity of trauma symptomatology. Comparisons were made between
participants who met full diagnostic criteria for PTSD (A=19) and those who did not
(N=l 1).
Results
Severity of drug dependence was positively correlated with trauma symptomatology and
with the number of traumatic events experienced. The comorbid PTSD-SUD group had
higher rates of psychological health problems and BBV risk than those with SUD only.
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There was no difference in rates of interpersonal conflict and a trend towards an
association with physical health problems.
Conclusions
Presence of PTSD is associated with higher rates of dependence, psychological distress,
and risk of acquiring a blood borne virus amongst injecting drug users. Comorbid
PTSD-SUD has been shown to negatively impact on treatment outcomes in individuals
with substance use disorders. These findings therefore support the need for integrated
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CHAPTER 1: INTRODUCTION
1.1 Definition of Substance Use Disorders (SUD)
The Diagnostic and Statistical Manual ofMental Disorders, 4th Edition (DSM-IV: APA,
1994) defines substance use disorder (SUD) as a collective term for substance abuse and
substance dependence. Substance abuse is characterised by repeated use of alcohol or
other psychoactive substances despite this resulting in significant clinical impairment or
distress, however use is not compulsive and there is no evidence of physiological
dependency (i.e. tolerance or withdrawal on cessation). Substance dependence, on the
other hand, typically involves three or more features over a twelve month period of:
compulsion to use; unsuccessful attempts to control or reduce use; preoccupation with
obtaining and using substances; persisting with use despite negative consequences;
increased tolerance; physical withdrawal. Substance dependence supersedes diagnosis
of substance abuse if an individual meets criteria for substance dependence.
In a study of individuals entering treatment for a substance use disorder in 2007/2008 in
Scotland, 17% (1587 individuals) of those who reported using heroin were resident in
the NHS Lothian area (ISD Scotland, 2008). Of those using heroin in Lothian, 22%
reported injection as the only route of administration, 13% reported using a combination
of intravenous and other methods (i.e. inhalation or intranasal use), and 65% reported
never injecting. Injecting drug use (IDU) has been associated with multiple health risks
such as inflammation of the veins, septicaemia, endocarditis, oedema, and transmission
of blood borne viruses such as HTV, hepatitis B and hepatitis C (Day & Crome, 2002).
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As around 35% of individuals entering treatment for heroin dependence report IDU, at
least 555 individuals in Lothian alone will have been vulnerable to these conditions due
to their injecting drug use. Furthermore, there are likely to be more injecting drug users
in Lothian who are not in contact with treatment services.
1.2 Definition of Post Traumatic Stress Disorder (PTSD)
Post Traumatic Stress Disorder (PTSD) may occur following a traumatic event where
the individual or another person suffers severe physical injury or their own or another's
life is in danger (Criterion A). PTSD is characterised by re-experiencing of the event in
the form of 'flashbacks' and nightmares (Criterion B), avoidance and emotional
numbing (Criterion C), and hyperarousal (Criterion D), which may cause significant
distress or impairment in social or occupational functioning (DSM-TV; APA, 1994).
The diagnostic criteria also require that the individual's response to the traumatic event
involves intense fear, helplessness, or horror and that that their symptoms persist for
more than one month. PTSD is therefore experienced by those who are unable to
integrate the experience of a traumatic event into their own histories (van der Kolk,
1996). The proportion of individuals who develop PTSD following a traumatic event
has been reported to be 8.1% of men and 20.4% of women (Kessler et al., 1995). The
prevalence in the general population is approximately 2-5% (Stein et al., 2000).
Individuals who have experienced a traumatic event who do not meet full DSM-IV
criteria for PTSD may be suffering from 'subthreshold' PTSD. Subthreshold PTSD is
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thought to be present when the individual reports significant impairment and distress and
at least one re-experiencing symptom, and either three avoidance or two arousal
symptoms (Blanchard et al., 1994). In a primary care sample, Grubaugh et al. (2005)
found the prevalence of subthreshold PTSD to be 4.6%. In addition to a subthreshold
form of PTSD, there is also some evidence to suggest that individuals who suffer
prolonged traumatic events or multiple traumas may develop an associated disorder
known as 'complex PTSD' or 'disorders of extreme stress not otherwise specified'
(DESNOS). Responses to traumatic events may therefore be seen as comprising a
spectrum of conditions rather than a single disorder (Herman, 1992).
1.3 Prevalence of Comorbid PTSD and SUD
The prevalence of PTSD in treatment-seeking patients with substance use disorders has
been found to be between 26-52% for lifetime PTSD and 15-41% for current PTSD
(Schafer & Najavits, 2007). Lifetime PTSD is diagnosed in individuals who experience
an episode where they meet criteria for PTSD at some point in their life but may not
exhibit current symptoms. Prevalence rates of lifetime PTSD tend to be higher than
rates of current PTSD. Prevalence of lifetime PTSD has been found to be 7.8% of the
US population and 1.9% of the population of Western Europe (Kessler et al., 2008).
Kimerling et al. (2006) validated a brief PTSD screen for use with a SUD population
and found that in a sample with 33% prevalence, 75% had previously undiagnosed
PTSD. They therefore argued that routine screening in SUD populations would increase
detection ofPTSD.
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Driessen et al. (2008) investigated the prevalence of PTSD in a sample of treatment-
seeking patients (N = 459) with substance dependence (alcohol, drugs, or both). They
used two standardized measures of PTSD: the International Diagnostic Checklist for the
ICD-10 (IDCL; Hiller et al., 1995) and the Posttraumatic Stress Diagnostic Scale (PDS).
As the IDCL has been found to have a lower diagnostic threshold than the PDS as it is
based on the ICD-10 criteria and not DSM-IV, participants were only diagnosed as
having PTSD if they met criteria for PTSD on both measures and were deemed
'subsyndromal' if they achieved a diagnosis on only one measure. It was found that
there was 78% agreement between the IDCL and the PDS, which resulted in a diagnosis
of PTSD in 25% of the sample, and the remaining 22% were classified as having
subsyndromal PTSD.
Two other groups were also included in this study: a trauma exposure group and a non-
exposure group. Drug dependent participants were found to have a current PTSD
prevalence of about 30% and those with comorbid drug and alcohol dependency had a
PTSD prevalence of about 34%, which was significantly higher than those with alcohol
problems alone who had a prevalence of 16%. The total prevalence of PTSD across all
groups was found to be 36-57% if subsyndromal PTSD was included. Trauma exposure
was present when individuals reported an event which met the DSM-IV criterion A for
PTSD and was found to be comparable across all groups at around 18% suggesting that
the higher rates of PTSD symptomatology were not a result of increased levels of
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exposure to traumatic events. Furthermore, the overall trauma exposure rate was found
to be comparable with that of the general US population.
A large scale study (N = 615) which was conducted in Australia looked at prevalence
and correlates of PTSD in a sample of individuals with heroin dependence (Mills et al.,
2005) found that 92% of participants had experienced trauma exposure and 41% met
criteria for lifetime PTSD. Of those individuals who had been exposed to a traumatic
event, 45% met DSM-IV criteria for current PTSD. Those participants with current
PTSD exhibited a chronic course with an average duration of 9.5 years. Significant
gender differences were observed with women more likely to have been raped or
sexually abused and men more likely to have experienced a life-threatening accident or
witnessed serious injury or death.
Reynolds et al. (2005) conducted a prevalence study with a UK sample of patients with
substance use disorders (N = 52). They found that 38.5% of inpatients met criteria for
current PTSD and 51.9% met criteria for lifetime PTSD, which is consistent with the
studies outlined above. In another UK study, Christo and Morris (2004) reported that
93.3% of current substance users, 80% of recently abstinent substance users, and 76.7%
of non-substance users in their sample (N = 205) reported having experienced a
traumatic event (as defined by DSM-ID-R; APA, 1987) at some point in their life. This
indicated a significantly higher tendency for active substance-misusers to report at least
one traumatic event compared to non-substance-misusers which is in keeping with Mills
et al.'s (2005) findings. The similar rates of trauma exposure between recently abstinent
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and non-substance users, in comparison to the higher rates reported in current substance
users, may indicate that trauma exposure may be a barrier to achieving abstinence.
Despite the largely consistent findings of prevalence in this population, it has been
argued that studies of PTSD in SUD populations are limited as "the variation in
substance use classification across studies hinders the direct comparison of comorbid
rates" (Johnson, 2008: 242). Johnson (2008) emphasises the need for studies to clarify
the types of substances used, the severity of substance use (e.g. substance abuse versus
dependence), and whether PTSD or trauma exposure is being measured. She also notes
that the nature of the trauma may influence outcome and that violent trauma may led to
more severe PTSD and SUD symptoms. The remainder of this review attempts to
address some of these issues.
1.4 Theories of Posttraumatic Stress Disorder
Early models of PTSD drew on a range of existing theoretical frameworks such as
psychodynamic theory (social-cognitive theories), learning theoiy (conditioning
theories) and information-processing theories (Brewin & Holmes, 2003). Each of these
three broad categories of theoretical model was limited by the dearth of empirical
evidence about PTSD that was available at the time. Nevertheless, they have provided
useful foundations for the subsequent models which are outlined below.
1.4.1 Emotional Processing Theory
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Emotional processing theory proposes that individuals with rigid beliefs about
themselves, others and the world would be more vulnerable to developing PTSD than
those who do not have such beliefs (Foa & Rothbaum, 1998). The model builds upon
Foa etal.'s (1989) fear network approach which suggests that perceived threats trigger a
pathological memory network of fear-related physiological, behavioural and cognitive
responses known as a 'fear structure'. Emotional processing theory states that
individuals who develop PTSD are more susceptible to engaging in negative appraisals
which in turn reinforce existing maladaptive schemas and fear structures. The theory
posits that there are two key negative beliefs involved in the formation and perpetuation
of posttraumatic symptomatology; the victim believes that the world is an extremely
dangerous place and that they are incapable of coping with stressful events (Foa &
Cahill, 2001; Jaycox etal., 2002).
The components of this model then provide a framework for therapeutic intervention
which consists of techniques such as psychoeducation about traumatic stress responses,
breathing retraining, imaginal and in vivo exposure, and cognitive restructuring. The
aim of this treatment is to assist individuals in processing the traumatic event by
modifying fear structures through activating them and providing disconfirming evidence
for the two negative schemas. This process breaks the fear associations which maintain
PTSD symptomatology and in turn promotes integration of the traumatic event and thus
recovery (Rauch & Foa, 2006). Studies which have evaluated this cognitive-behavioural
treatment approach have demonstrated its efficaciousness and it is recommended as the
treatment of choice for PTSD in both the United Kingdom and the United States of
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America (ISTSS, 2009; NICE, 2005). However, it has also been suggested that the
mechanisms which yield these improvements may not be fully explained by the
information processing model and there have been criticisms that it does not account for
phenomena such as dissociation and incomplete trauma narratives (Brewin & Holmes,
2003).
1.4.2 Dual Representation Theory
The dual representation model of PTSD outlines two features which explain PTSD
symptomatology. These are, firstly, the existence of two types of memory about the
traumatic event and secondly, the possibility that some individuals will engage in
premature inhibition of emotional processing (Brewin et a/., 1996). The two types of
trauma memory are referred to as 'verbally accessible memories' (VAMs) and
'situationally accessible memories' (SAMs). VAMs are forms of autobiographical
memory which contain some information about the traumatic event and can be
consciously retrieved and shared with other people. They may also contain gaps or
incomplete representations due to limited attentional capacity associated with high levels
of anxiety, and it is thought that this may be particularly relevant in cases where a
traumatic event is prolonged or repeated. In contrast, SAMs are only accessed
automatically when salient internal or external cues are encountered. The other
distinctive feature of the dual representation model is the inclusion of three potential
outcomes of emotional processing: complete processing or integration, chronic
emotional processing, and premature inhibition of processing.
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Chronic emotional processing refers to a state where individuals repeatedly process both
the VAMs and SAMs concerning the traumatic event but with little or no change to the
representations. This then results in a chronic state of hyperarousal and the ongoing
presence ofmemory and attentional biases towards trauma-related material. A potential
side effect of chronic emotional processing is secondary psychopathology such as
anxiety or depression and the development of maladaptive coping responses such as
substance abuse. The other incomplete form of emotional processing is premature
inhibition which occurs when there has been repeated avoidance of SAMs and VAMs.
If this process becomes automatic, it can result in a lack of intrusive memories and an
ability to relate aspects of the trauma without experiencing negative emotions. It is also
associated with dissociation and somatisation, and clinically can explain why some
individuals with PTSD may benefit from exposure techniques to facilitate emotional
processing years after the traumatic event. In addition to behavioural interventions such
as exposure, Brewin et al. state that their model also sets a rationale for the necessity of
using cognitive therapy techniques prior to the use of exposure, to tackle negative
appraisals and secondary negative emotions such as anger or guilt.
1.4.3 Cognitive Model ofPTSD
In their cognitive model of PTSD Ehler and Clark (2000) proposed that the disorder
arises when individuals who have experienced a trauma process it in such a way that
they develop a sense that the risk of serious danger is ongoing. This occurs when
individuals engage in negative appraisals of the trauma or their PTSD symptoms. Such
negative appraisals include external and internal threats such as those outlined in Foa
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and Rothbaum's (1998) emotional processing model. The other process which is
proposed as potentially leading to the development of PTSD is the way in which the
trauma is encoded in memory and its link to other autobiographical memories. The
model proposes that individuals who develop PTSD fail to properly integrate the trauma
memory in their autobiographical memory and respond strongly to conditioned cues
associated with their trauma which leads to unintentional and intrusive recollections and
experiences. Re-experiencing is also associated with implicit memory traces due to a
reduced perceptual threshold for stimuli that were temporally associated with the
trauma. This aspect of the model aims to address the encoding of trauma memories and
does so in a rather different way to the dual representation model (Brewin et al., 1996)
as it only proposes one trauma memory, not two. The sequelae explained by Brewin et
al., as arising from SAMs and VAMs is better accounted for with the cognitive model
which cites poor elaboration of autobiographical memory and classical conditioning.
The cognitive model of PTSD also seeks to explain key features of the disorder such as
delayed onset. This is thought to occur when a later event leads to a reappraisal of the
initial event, rendering it more threatening in the mind of the victim, or when stimuli
associated with the trauma are only encountered some time after the event. Like the
other two theories, the model also proposes an explanation for the lack of benefit arising
from talking or thinking about the trauma due to the failure to experience related affect
and thus preventing the opportunity to contextualise the event in memory. The cognitive
model fits with the cognitive behavioural treatment approach, particularly as there is a
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strong emphasis on negative appraisals in the development and maintenance of PTSD
which would be most effectively addressed with cognitive restructuring.
1.5 Theories of the Relationship between PTSD and SUD
Three main hypotheses have been proposed to explain the relationship between PTSD
and SUD.
1.5.1 Self-Medication Hypothesis
The self-medication hypothesis suggests that substance use disorders may develop as a
method of coping with the adverse reactions associated with experiencing a traumatic
event. Reed et al. (2007) conducted a longitudinal study (N = 988; aged 19-24 years)
which found that the risk of developing substance abuse or dependence was six times
higher in individuals who had PTSD compared to those who had not been exposed to
trauma (lifetime exposure to at least one traumatic event as defined by DSM-IV criterion
A), with the PTSD group twice as likely to develop a SUD compared to those who were
exposed to a traumatic event but did not develop PTSD. Based on their findings, the
authors suggested that PTSD may be a risk factor for individuals with emerging drug
problems and may lead them to progress to having a diagnosable substance use disorder
as a result of their attempts to self-medicate.
The functional associations between trauma, PTSD and substance-related disorders have
also been investigated (Stewart et al., 1998). In keeping with the findings of Reed et al,
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their literature review determined that in most cases traumatic events occurred prior to
the onset of substance misuse. They argue that the majority of studies which were
reviewed support the self-medication hypothesis of the relationship between PTSD and
SUD. They also acknowledge that prospective and longitudinal studies may present
evidence of other functional associations between PTSD and SUDs that are unlikely to
be unidirectional, rather there is a vicious cycle where PTSD leads to self-medication
and symptoms may in turn be exacerbated by substance use. Furthermore, the PTSD
self-medication model may apply to a more general negative affect including anger,
anxiety and depression (Ouimette et al., 2007). This suggests that individuals may use
substances to reduce the impact of any negative affect and therefore this process is not
unique to individuals with PTSD.
Fisher (2000) proposed that this misuse of substances to cope with PTSD symptoms
functions as a survival mechanism in the short-term as it allows individuals to distance
themselves from intrusive memories or reduce their level of arousal. This then leads to
addiction in the longer-term when the dose required to maintain the self-medicating
effect and prevent physical and emotional withdrawal increases: "the substance use
gradually acquires a life of its own that, over time, becomes increasingly dismptive to
the patient's functioning until it is a greater threat to that individual's life than the
symptoms it attempts to keep at bay" (emphasis in original, p. 1). Substance use can
therefore be conceptualised as an attempted way of controlling symptoms without
depending on others.
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1.5.2 High Risk Hypothesis
This hypothesis proposes that substance use disorders are part of a wider group of high-
risk behaviours which increase the risk of exposure to potentially traumatic events and
therefore increases the risk of developing PTSD. Johnson et al. (2006) investigated the
temporal association between exposure to traumatic events and substance use onset.
Their hypothesis was that substance use would precede the onset of PTSD in
polysubstance users. They recruited a sample of injecting drug users who used crack
cocaine and/or heroin (N= 1098). The hypothesis was supported by the findings which
showed that onset of polysubstance use began prior to experiencing the traumatic event.
On average, male heroin users began using heroin eight years prior to exposure to a
traumatic event whilst female heroin users began using heroin before experiencing a
traumatic event but within one year of exposure. Women were more likely to
experience the qualifying event earlier than men and early alcohol use was found to be a
risk factor for women. Crack cocaine was the only substance where use was initiated
subsequent to trauma exposure, and this may be related to re-experiencing symptoms as
stimulants have been shown to decrease shame and guilt associated with trauma and
reduce re-experiencing symptoms by producing a chemical barrier or "high" (Fisher,
2000; Saladin etal., 1995).
These findings also appear to support the work of Cottier et al. (2001) who investigated
the role of gender in the relationship between substance use disorders and PTSD. They
found the prevalence of trauma exposure to be 36% and that those who met criteria for
SUD were more likely to report lifetime trauma exposure. As reported in other studies,
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women were significantly more likely to report rape than men and men were
significantly more likely to report being physically assaulted than women. Of those
reporting exposure to a traumatic event, 18% met criteria for PTSD. Women were more
likely to meet criteria for PTSD than men. Interestingly, while polydrug use, injecting
drug use and presence of an SUD disorder were predictive of exposure to trauma, they
were not associated with a progression to PTSD. Individuals with pre-existing
schizophrenia, generalised anxiety disorder, or a phobic disorder were more likely to
develop PTSD following exposure to a traumatic event. Onset of illicit drug use was
found to occur on average seven years prior to the traumatic event. When divided by
gender, this was an average of four years pre-trauma for women and eight years pre-
trauma for men. Together these findings support the high risk hypothesis and Cottier et
aVs (2001) findings for male participants are in keeping with those of Johnson et al.
(2006).
1.5.3 Vulnerability Hypothesis
The vulnerability hypothesis, also referred to as the 'susceptibility hypothesis', proposes
that individuals who engage in substance misuse are more susceptible to developing
PTSD following exposure to a traumatic event. Various explanations have been given
for this association including pre-existing affect dysregulation, cognitive impairment due
to chronic substance abuse, or limited coping mechanisms.
Higher childhood sexual abuse (CSA) severity is associated with increased risk of
comorbid PTSD and SUD (Ullman, Townsend et al., 2006). Kingston and Raghavan
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(2009) investigated associations between sexual abuse, early initiation of substance use,
and adolescent trauma. Their findings did not support their hypotheses that CSA would
predict a younger age of first use of substances or exposure to additional traumatic
events. However, a younger age of first substance use was significantly associated with
subsequent exposure to additional traumatic events and risky behaviour. Risky
behaviour and additional traumatic events in turn were significantly associated with
current PTSD. These findings led the authors to conclude that "early substance use
initiation may increase the risk of exposure to traumatic events due to poor judgement
caused by intoxication and other correlates of early substance use such as a propensity
for risk taking and association with delinquent peers" (p. 67). Their model would
therefore suggest that CSA may have an indirect influence on later SUD and PTSD, by
way of a vulnerability created by adverse childhood events.
A large-scale study in the United States investigated the link between multiple forms of
childhood maltreatment and adult mental health in a community sample (The Adverse
Childhood Experiences (ACEs) Study: Edwards et al., 2003). The authors found a dose-
response relationship between the number of types of maltreatment and mental health
scores. It was also found that more than one third of the sample had experienced more
than one form of maltreatment. In keeping with the findings of adult traumas, women
were significantly more likely to report higher rates of childhood sexual abuse (25.1%)
and men reported significantly higher rates of physical abuse (21.7%). Women reported
significantly more levels of emotional abuse than men and this was associated with
higher levels of mental health disorders. Significant main effects were found for the
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number of reported types of abuse, intensity of emotional abuse, and the interaction
between these two factors. This led the authors to conclude that "multicategory abuse is
the norm rather than the exception" (p. 1459).
Another paper based on this study investigated the associations between childhood
maltreatment, household dysfunction and morbidity and mortality in later life (Felitti et
al., 1998). It reported that multiple categories of childhood exposure to maltreatment
were associated with multiple health risk factors including smoking, severe obesity,
physical inactivity, depressed mood, suicide attempts, alcoholism, drug abuse, parental
drug abuse, high lifetime number of sexual partners, and history of sexually transmitted
infections. Seven categories of maltreatment were investigated: psychological abuse,
physical abuse, sexual abuse, living with adults with substance abuse, mental illness,
maternal battery, or a member of the household being imprisoned. The study reported
that 25.6% of the sample had childhood exposure to substance abuse in their household.
A comparison of those with no experience of childhood maltreatment (47.9% of the total
community sample) with those who had experienced four or more forms of maltreatment
(6.2%) showed a ten fold increase in the likelihood of injecting drug use. Multiple
experiences of maltreatment were found to increase the likelihood of individuals
engaging in health risk behaviours such as smoking, alcohol or drug use, overeating or
sexual behaviours as coping strategies and these could become chronic. These coping
strategies may arise as a result of chronic emotional processing and the high levels of
arousal arising from this, or may lead to premature inhibition of emotional processing, as
outlined by the dual representation theory.
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The cumulative impact of childhood sexual abuse, adult sexual assault, and intimate
partner violence has also been examined (Follette et al., 1996). They reported that
scores on the Trauma Symptoms Checklist indicated that participants who had
experienced greater numbers of traumatic events had significantly higher levels of
trauma symptomatology. This finding highlighted that recent traumas may exacerbate
symptoms from previous traumatic experiences and multiple trauma exposure may also
impact on the recovery rate from subsequent trauma, supporting the hypothesis that
repeated exposure to trauma has a cumulative effect. From these results, Follette et al.
hypothesised that revictimisation may be more likely to occur in individuals with
substance use disorders as the use of chemically or psychologically induced dissociation
may lead to risk of further traumatic events. Additionally, it is possible that adverse
early experiences may result in specific skills deficits which increase the risk of
revictimisation. These findings may also fit with emotional processing theory as
multiple early adverse experiences may lead to the development of fear structures in
childhood and maladaptive schemas which are activated and reinforced by later
traumatic events.
The incremental effect of exposure to violence on mental health status has been
investigated by Hedtke et al. (2008). Their study of womens' exposure to violent events
reported that five of the seven lifetime exposure categories (including physical abuse,
sexual abuse, and a combination of these factors plus witnessing violence) were
significant predictors of exhibiting PTSD within the past year. All categories, with the
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exception of witnessing violence only, were predictive of a major depressive episode
and this risk was higher when multiple categories of violence were experienced.
Similarly, all violence categories, with the exception of witnessing violence only, were
predictive of substance use problems with multiple categories and experiencing a new
violent event in the past year being significant risk factors. The only factor which
predicted further victimisation over a one year period was having a history of PTSD -
major depressive disorder and substance use problems were not found to increase the
risk of subsequent traumas.
Messman-Moore & Long (2003) conducted a comprehensive review of studies
pertaining to the sequelae of childhood sexual abuse in women and their association with
sexual revictimisation. These sequelae included posttraumatic stress disorder,
dissociation, substance abuse, sexual behaviour, risk recognition difficulties, and
interpersonal difficulties. It was hypothesised that substance abuse functions as a form
of 'chemically induced dissociation' and therefore allows individuals to engage in
avoidance of aversive internal and external experiences. However, it has also been
shown that intoxication increases the likelihood of rape or sexual assault and substance
abuse may be a predisposing factor for revictimisation. Difficulties with risk recognition
were not supported as factors relating to revictimisation in the literature reviewed. Some
evidence was found to support the role of sexual behaviour and interpersonal
functioning as factors contributing to revictimisation, although results were mixed and
require further investigation. The relationship between PTSD and revictimisation was
also unclear, due to the retrospective nature of studies, as it may function as either an
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underlying causal mechanism by triggering dissociation, or as an outcome of
revictimisation. In addition to this, studies were also presented which appeared to lend
support to the 'sensitization hypothesis' that individuals with early traumatic
experiences would experience a sensitization of the hypothalamic-pituitary-adrenal
(HPA) axis and that hyperarousal and numbing may desensitize or delay appropriate
responses to risk or danger. This process is seen as bidirectional and interactive, and
therefore causality is extremely difficult, if not impossible, to determine. For individuals
with problem substance use, this process is also likely to be influenced by the impact of
substances on cognitions, emotion regulation, and coping mechanisms.
Hien et al. (2005) undertook a review of the literature to determine associations between
traumatic stress, substance use disorders, and self-regulation. Their examination of
prospective studies supported the hypothesis that early trauma exposure occurs prior to
substance use in some cases and dysregulation of emotion may be a key feature in the
development and chronicity of substance abuse and dependence. They go on to explore
the links between early traumatic experiences and development of self-regulatory
mechanisms which indicate that individuals with early adverse experiences exhibit fewer
adaptive coping strategies, have difficulties containing strong emotions, and are more
likely to doubt the ability of others to provide them with support in difficult situations.
These difficulties are thought to be attenuated if such individuals encounter subsequent
revictimisation in adulthood, leading to problems associated with poor affect regulation
and interpersonal functioning. Furthermore, the reviewers highlight the structural
changes of the limbic system resulting from traumatic experiences which lead to
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disruption of self-regulatory functions. This is thought, in turn, to lead to increased
vulnerability to substance use as individuals attempt to overcome deficits in self-
regulation (Brady, 2001).
Pirard et al. (2005) investigated the link between a history of physical and/or sexual
abuse in childhood and addiction treatment in a study of 700 substance abusers who
were seeking day or residential treatment. It was found that 47.3% of the sample
reported a history of abuse in childhood and the remainder did not. Those individuals
with a history of childhood abuse were found to have significantly higher rates of
psychiatric comorbidity and more psychiatric hospitalisations in a one-year period than
those without such a history. No differences were found on severity of drug use, the
number of previous treatments for substance abuse, or rates of engagement in treatment.
However, this study looked purely at the effects of physical or sexual abuse in childhood
and did not address issues associated with other traumas in childhood or adulthood.
There is also a question as to whether the similar rates of addiction severity between the
trauma-exposed and non-trauma-exposed group are due to the fact that individuals with
more complex trauma histories may have higher rates of addiction severity and an
associated chaotic lifestyle which prevents them from entering intensive substance abuse
treatments such as this one.
Christo and Morris (2004) investigated the prevalence of traumatic event prevalence and
anxiety in a UK sample of current substance users, recently abstinent substance users
and non-substance users. All participants completed the State Trait Anxiety Inventory
30
(STAI) and the National Comorbidity Study List of Lifetime Traumatic Events (NCS-
LTE) which is based on DSM-III-R criteria for a traumatic event. The participants were
also invited to indicate how often they thought about the traumatic event(s). It was
found that current substance users were significantly more likely to have experienced a
traumatic event than non-substance users. The average number of traumas endorsed and
the rate of childhood sexual abuse were significantly higher in the substance use group
than the non-substance use group. The number of male survivors of CSA was eight
times higher in the substance use group. Almost one third of traumatic events were
rated as having a high impact as determine by a rating of having 'thought about it often
or almost always'. However, given that individuals with substance use disorders have a
tendency to report intrusion symptoms less often then avoidance/numbing or
hyperarousal symptoms, this may not be the best method of determining severity of
impact.
Rates of anxiety were found to be similar in current and recently abstinent substance
users and both of these groups showed significantly higher rates of anxiety compared to
non-substance users. Further analyses confirmed that the groups did not differ in terms
of age, gender or socioeconomic status. A significant positive correlation was found
between the overall number of 'high impact' events (but not overall number of traumatic
events) and level of anxiety. One limitation of this study is that it does not measure all
features of PTSD. The authors also suggest that early traumatic experiences do not
impact on current anxiety levels and that temporal proximity to trauma should be
considered in treatment. However, they do not address the role of dissociation,
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avoidance, and the link between early traumatic experiences and later victimisation.
They acknowledge that withdrawal effects from substances such as benzodiazepines and
opiates mimics biological symptoms of PTSD and may increase vulnerability to relapse
(Young, 1990). There is also a discussion of potential causal pathways between PTSD
and SUD, which they conclude is unlikely to be "mutually exclusive".
1.6 Impact of PTSD and SUD
1.6.1 Impact ofPTSD-SUD on Presentation
Individuals with both PTSD & SUD (PTSD-SUD) are more likely to have vivid
recollections and use certain substances (i.e. depressants) in order to 'forget' or mitigate
these intrusions compared to individuals with PTSD only (Stewart et al., 1998).
Similarly, substances which dampen arousal may be used to reduce PTSD-related
hyperarousal. Saladin et al. (1995) conducted two studies looking at traumatic event
exposure and severity of PTSD symptoms. They found that individuals with comorbid
PTSD-SUD had a greater number of PTSD symptoms in the Criterion C
(avoidance/numbing) cluster and Criteria D (arousal) cluster than the PTSD only group.
These group differences were most evident for the arousal symptom of sleep
disturbance. The authors point out that one potential reason for the greater endorsement
of these clusters is that they have greater overlap with withdrawal and other features of
chronic substance use such as loss of interest and feeling detached from others.
Conversely, there is no difference in trauma-specific symptoms as illustrated by the
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Criterion B (intrusion) cluster. This suggests that differences in presentation between
individuals with PTSD who have comorbid SUD and those who have PTSD alone may
be due in part to symptoms which result from chronic substance use.
However, another study found that SUD was associated with worse intrusive and
avoidance symptoms of PTSD and with dissociation (Ford et al., 2007). This led the
authors to propose that survivors of early victimization traumas are subject to
disruptions of psychobiological regulation which gives rise to complex PTSD. Complex
PTSD is a post-traumatic syndrome which occurs in some individuals who have been
exposed to prolonged, repeated trauma (Herman, 1992). PTSD and complex PTSD may
co-occur but have different risk factors and clinical correlates (Ford, 1999). The impact
of complex PTSD on treatment for substance use disorders may include difficulties with
engagement, skill-learning, and achieving abstinence from illicit substances. Complex
PTSD was found in the Ford (1999) study to be correlated with PTSD symptoms,
psychological distress, and past physical abuse, witnessed assault and serious life
threats. An inverse correlation was found between complex PTSD following witnessing
an assault and treatment retention and in-treatment abstinence. Where participants with
complex PTSD were divided by a median split, those in the Tow' complex PTSD were
found to be older and have longer histories of heroin use than those with 'high' complex
PTSD, however the severity of drug use was not investigated. No differences were
found in the multivariate predictors when continuous scores were used in place of
dichotomous scores, suggesting that the median split was an acceptable way to compare
these two groups.
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Rash et al. (2008) investigated the correlates of PTSD/SUD in a sample where all
participants had experienced a crime-related traumatic event. They found that the use of
opiates was very low (2.4%) compared to the use of alcohol and cocaine (72.6% and
50.8% respectively). Participants who did not meet the criteria for PTSD were found to
exhibit some post-traumatic symptoms although there is an overlap with these symptoms
and withdrawal symptoms, generalised distress, and other psychiatric conditions. These
symptoms may therefore make it difficult to accurately diagnose PTSD in SUD
populations. The authors suggested that Criterion C (avoidance) symptoms are the most
important in discriminating PTSD participants from the rest of the sample.
1.6.2 Impact ofPTSD-SUD on Functioning
In the Mills et al. (2005) study, PTSD was associated with first intoxication at a younger
age, more polydrug use, longer using careers, higher rates of previous treatment
attempts, and poorer physical and mental health. The study reported that there were no
differences in age of first heroin use or frequency of use prior to starting treatment
between those with and without PTSD. It was found that participants with and without
PTSD were equally likely to have been involved in criminal activity, but those with
PTSD were significantly more likely to be involved in violent crime. No differences
were observed between groups for risky injecting behaviours. Factors associated with
current PTSD were older age, female gender, borderline personality disorder,
nominating sexual abuse as the most distressing event, and having experienced a greater
number of traumatic events.
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Reynolds et al. (2005) hypothesised that the PTSD-SUD population would be more
impaired than those who had SUD-only and that inpatients would have more severe
difficulties than outpatients. The findings indicated that those with PTSD-SUD had
experienced more sexual assaults, more multiple traumas, and higher levels of distress
than those with SUD-only. The PTSD-SUD group also had significantly higher
Addiction Severity Index (ASI) medical scores, higher psychiatric ratings on the Brief
Symptom Inventory (BSI), and higher scores on the psychoticism subscale. Individuals
with PTSD-SUD were found to have higher rates of polydrug use prior to entering
treatment and rated traumatic memories as being significantly more distressing both
before and after ceasing drug use. The PTSD-SUD group were also more likely to
report an increase in frequency of traumatic memories following cessation compared to
the non-PTSD SUD group. This finding suggests that substances were used by
individuals in the PTSD-SUD group to inhibit emotional processing and again gives
some support for the dual representation model.
1.6.2.1 Severity ofdependence on substances and PTSD
In addition to measuring prevalence of PTSD, Driessen et al. (2008) measured severity
of substance use using the Addictions Severity Index (ASI; McLellan et al., 1992) and
three groups were identified: an alcohol only group; a drugs only group; and a comorbid
drugs and alcohol group. The hypothesis that meeting full criteria for PTSD would be
associated with more severe substance dependence than subsyndromal PTSD or trauma
exposure only was partly supported by the finding that those with PTSD had
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significantly higher levels of craving for substances than participants in the
subsyndromal, trauma exposure, and non-exposure groups. It was also reported that
subsyndromal PTSD was associated with increased psychopathology, as measured by
the Brief Psychiatric Rating Scale (BPRS), and this was significantly higher than in the
exposure and non-exposure groups. However, the prediction that the subsyndromal
group would have higher levels of addiction severity and dependence compared to the
exposure group was not supported.
Additionally, it was found that the 'exposure' group was comparable with the 'non-
exposure' group in terms of addiction severity, suggesting that other psychopathology
such as anxiety/depression or coping style may differentiate between those who do and
those who do not develop PTSD. Similarly, Bonin et al. (2000) compared a PTSD,
subsyndromal PTSD, and non-PTSD group of individuals enrolled in substance use
disorder treatment. They found that participants with PTSD and subsyndromal PTSD
reported significantly higher rates of substance use to cope with difficulties than those
who did not meet criteria for PTSD. The findings of these studies also highlighted that
at least two aspects of dependency were associated with comorbid PTSD and SUD.
These features were compulsion to use (craving or perceived inability to abstain when
triggered by salient cues) and cognitive set (the belief that substance use has become
central to the individual's existence). These negative appraisals are similar to those
outlined in both Foa and Rothbaum's (1998) and Ehler and Clarke's (2000) models as
they present the self as incompetent (unable to refuse substances) and the world as
dangerous (substances cannot be avoided).
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Clark et al. (2001) compared a sample of one hundred and fifty individuals enrolled in
treatment for opiate dependence. The study aimed to determine the effect of exposure to
traumatic events and PTSD symptomatology on severity of drug use and the findings
suggested that recency of PTSD symptoms was a significant factor in predicting drug
use severity scores. PTSD was also significantly associated with higher rates of
additional psychopathology and having a history of suicide attempts when compared
with those who did not have PTSD. The authors point to the need for early integrated
treatment for PTSD-SUD in order to reduce the likelihood of relapse as recent PTSD
symptoms were shown to increase severity of drug use. This relationship therefore
suggests that both disorders require to be treated in order to maximise chances of
recovery.
1.6.2.2 Cumulative trauma and dependence
Bonin et al. (2000) conducted a study which looked at the prevalence of PTSD and
subsyndromal PTSD in a sample of substance users attending community-based
treatment. Their results indicated that individuals who met criteria for PTSD had
experienced significantly more potentially traumatic events than those without PTSD.
Individuals with PTSD exhibited significantly higher severity of substance dependence
than those with subsyndromal or no PTSD suggesting that those with cumulative trauma
had higher rates of dependence. While this is an interesting finding, the study is limited
by the small sample (N = 91) which may have made it difficult to detect differences
between the three groups (PTSD, 'possible' PTSD, and no PTSD). Ullman, Townsend
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et al. (2006) investigated comorbid PTSD and polysubstance use in a sample of women
who had experienced sexual assault. They divided the sample into four groups
depending on whether the participants had PTSD only (47%), PTSD and illicit drug use
(8%), PTSD and alcohol abuse (21%), or PTSD and polysubstance use (24%).
Participants with polysubstance use and PTSD were found to have significantly more
extensive trauma histories and greater use of substances as a coping mechanism when
compared to all other groups. As those individuals who had experienced a greater
number of traumatic events were found to have greater reliance on substances, it seems
that the cumulative effect of trauma may predispose them to more severe and/or
polysubstance dependence.
1.6.2.3 PTSD-SUD and Physical health
Ouimette et al. (2006) aimed to address the relationship between the health and
functional status of SUD participants with and without PTSD. They hypothesised that
participants with PTSD-SUD would report more chronic physical symptoms and poorer
functional status and well being than patients with SUD alone. The sample comprised
133 inpatients in a private hospital setting. Homelessness was an exclusion criterion,
and almost half of the sample had college-level education and worked full-time. The
results indicated that participants with comorbid PTSD-SUD reported more
cardiovascular and neurological symptoms than those with SUD alone and had a greater
number of chronic physical symptoms. The participants with PTSD-SUD also reported
significantly worse physical functional status on measures of bodily pain and general
health. With regard to mental health, PTSD-SUD participants also reported worse
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functional status and wellbeing than those with SUD alone. This remained significant
after controlling for gender, ethnicity, and chronic physical symptoms. SUD was found
to be associated with poorer functional health and wellbeing however PTSD increased
this risk. Given the socioeconomic status of this particular sample, it is difficult to
determine to what extent these findings can be generalised. The authors also note that
their data are cross-sectional and therefore causality cannot be inferred.
Tate et al. (2007) also investigated the association between trauma exposure and
physical health in substance-dependent veterans. Their hypothesis was that individuals
with comorbid PTSD and SUD would have the most health problems, followed by those
with trauma exposure and SUD, and then the SUD-only group. They found that the
SUD-only group had significantly lower rates of physical health problems than the other
two groups. The PTSD-SUD had the highest rates of physical health problems, but
these were not significantly higher than the SUD-trauma group. The PTSD-SUD
exhibited the highest rates of chronic health problems, followed by the SUD-trauma
group, and the SUD-only group reported significantly fewer chronic health problems
than the other two-groups. The groups did not differ with regard to the type of chronic
health problems reported and there were no differences between groups with regard to
rates of acute health events. The SUD-only group was found to have less health service
utilization days and rated their health as significantly better than the PTSD-SUD group.
A potential explanation for the higher rates of physical health problems in the PTSD-
SUD group was their increased exposure to repeated cycles of adaptation to stress. This
39
may had led to an increase in allostatic load which in turn leads to increased
susceptibility to illness.
1.6.2.4 PTSD-SUD and Psychological health
Bonin et al. (2000) also found that individuals with PTSD and SUD reported
significantly higher levels of psychological distress on standardised measures
(depression, anxiety, and sensitivity to anxiety) compared to those without comorbid
PTSD. Similarly, Wasserman et al. (1997) found that participants in their study of
cocaine-dependent individuals enrolled in private SUD treatment were significantly
more likely to have a current major depressive episode, manic episode, panic disorder,
simple phobia, or dependence on sedatives if they were diagnosed with PTSD than those
who had SUD alone. The authors suggest that this increase in psychopathology may be
due to an overlap in symptom criteria between PTSD and other psychiatric diagnoses.
However, they also note that PTSD is only one potential outcome following the
experience of a traumatic event and some individuals may go on to develop multiple
disorders.
The impact of comorbid PTSD- SUD on psychiatric treatment rates has been
investigated by Brown et al. (1999). They found that 50% of their inpatient sample met
criteria for current PTSD and 95% had been exposed to a Criterion A event in their
lifetime. Similar to other studies, female participants were significantly more likely to
have experienced rape and adult physical abuse than male participants. Women also
experienced significantly more types of trauma. No differences were found between
40
PTSD and non-PTSD participants on substance use behaviours such as frequency or
severity of use or on the overall rates of using inpatient or outpatient addiction or
psychiatric services. Whilst no differences were found between groups on use of
addiction or psychiatric services, individuals with comorbid PTSD-SUD had a
significantly greater number of overnight stays for SUD-related treatment which was
much more costly than other forms of treatment. The finding that PTSD participants
made significantly greater use of overnight inpatient stays was therefore thought to be
due not to more severe or chronic SUD but possibly due to coping or personality style.
This seems possible as the PTSD group had significantly higher rates of comorbid Axis I
disorders compared to the non-PTSD group and greater rates of psychiatric distress.
They also had higher rates of Cluster B personality disorder symptoms, i.e. antisocial,
histrionic, borderline, and narcissistic personality disorders, which have been termed
"flamboyant and dramatic" (Davidson, 2007). This apparent vulnerability to the
development of a personality disorder fits with the cognitive model of PTSD - which
proposes that PTSD arises from difficulties in integrating traumatic events into
autobiographical memory - as this may give rise to problems in forming a coherent
sense of identity. The impact of intrusions on affect and behaviour may also explain
some of the characteristics of Cluster B personality disorders. Further analysis of the
data also indicated that PTSD was a significant factor in determining admissions to
psychiatric inpatient facilities when other comorbidities were controlled for. These
findings suggest that PTSD-SUD patients are not receiving the psychiatric input that
they require.
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Strengths of this study were that it had an adequate number of participants for a
prevalence study (N = 95); the measure used to diagnose PTSD, the Clinician
Administered PTSD Scale (CAPS; Blake et al., 1990), has been considered to be the
"gold standard"; and the inclusion of a corroborative source of reported traumatic
events. Potential limitations were the recruitment of patients from a private psychiatric
hospital and the exclusion of individuals who were homeless or illiterate. As these
criteria would have excluded most of the substance-misusing population, these results
may not be generalisable to this wider population.
1.6.2.5 Risk-taking behaviour and PTSD-SUD
Reed et al. (2007) found that being male, having fewer years of education, and high
early risk taking had statistically significant associations with developing a substance
use disorder and PTSD. Risk taking behaviour has also been highlighted as a factor in
developing PTSD in individuals with early experiences of trauma (Felitti et al., 1998;
Kingston & Raghavan, 2009).
1.6.2.6 Interpersonalfunctioning and PTSD-SUD
The role of PTSD diagnosis in relapse was investigated by Sharkansky et al. (1999) in a
sample of substance users enrolled in a relapse prevention programme. The findings
indicated that individuals with comorbid PTSD and SUD were significantly more likely
to relapse following interpersonal conflict, and after experiencing physical discomfort or
unpleasant emotions but not in other high-risk situations such as social pressure to use or
experiencing urges to use. Based on these findings, it was proposed that individuals
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with PTSD-SUD may require multiple strategies to prevent relapse and trauma-focused
interventions may also be of value.
Schiff et al. (2002) investigated the associations between intimate partner abuse, drug
use, childhood sexual abuse, and psychological distress. The sample comprised female
participants from urban methadone maintenance treatment programmes who were given
standardised psychometric measures. Women who met criteria for PTSD were more
likely to report polydrug use over a six-month period and they were significantly more
likely to exhibit injecting drug use than women without PTSD. Furthermore, women
who were abused by their partners were found to have significantly higher rates of
posttraumatic stress symptoms than non-abused women; however they were not any
more likely to meet full criteria for PTSD. These findings therefore suggest that
intimate partner violence, a potential consequence of interpersonal conflict, is associated
with higher levels of posttraumatic symptomatology.
Self-blame, avoidance coping and negative social reactions to disclosure were found to
be related to increased PTSD symptoms and better social support was found to be a
protective factor against PTSD (Ullman, Townsend et al., 2006). Again, these findings
fit with both the emotional processing and cognitive models of PTSD as they suggest
negative appraisals are a key factor in the development and maintenance of PTSD.
1.6.3 Impact on Treatment Outcome
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1.6.3.1 Potentialfor Treatment Drop-Out
Hien et al. (2000) investigated the impact ofPTSD on short-term treatment outcomes in
a sample of ninety-six individuals who attended an opiate-substitute (methadone)
prescribing programme. Their results indicated that PTSD did not lead to increased
likelihood of treatment drop-out; however it was associated with significantly higher
rates of polysubstance use at three-month post-admission and thus significantly poorer
treatment adherence than those without PTSD. It was therefore concluded that PTSD
was a significant factor in poorer treatment outcomes. An earlier study of pregnant
substance abusers enrolled in a residential treatment programme found that diagnosis of
PTSD but not trauma exposure was significantly associated with failure to complete
treatment (Thompson & Kingree, 1998).
1.6.3.2 Likelihood ofRelapse to Substance Misuse
The relationship between trauma history, PTSD symptoms, and addiction relapse has
been investigated by Norman et al. (2007). The participants were veterans who attended
an abstinence-based treatment programme and were divided according to whether they
had SUD only, trauma exposure and SUD, or comorbid PTSD-SUD. Around 24% of
the total sample met criteria for PTSD and 80% of the trauma-exposed sample met
criteria for at least one PTSD symptom cluster. Each participant completed a
comprehensive psychiatric evaluation which included measures of substance use
disorder, PTSD, and other mental health disorders. These symptoms were then
investigated to determine if these were cues to addiction relapse following a period of
abstinence. The PTSD-SUD group endorsed significantly more symptoms than the
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SUD-trauma and SUD-only groups prior to relapse. Following relapse, the PTSD-SUD
reported significantly more anxiety and psychotic symptoms than the other two groups.
Participants relapsed most frequently in 'temptation' contexts where they had enhanced
emotional states, were testing their personal control, or gave in to temptation, and no
differences were detected in the frequency of these situations. Logistic regression
analyses indicated that psychiatric symptoms predicted the contexts associated with
relapse. In particular, anxiety and PTSD symptoms significantly predicted relapse in
negative interpersonal contexts. Relapse was also predicted by PTSD symptoms in
situations where participants experienced negative physiological states but appeared to
reduce likelihood of relapse in social pressure contexts. No differences were found in
post-treatment substance use disorder outcomes between the three groups, which did not
support the hypothesis that the PTSD-SUD and SUD-trauma groups would have poorer
outcomes than the SUD-only group. This led the authors to propose an alternative
hypothesis: that relapse to substance use may impede remission of PTSD rather than
PTSD leading to poorer substance disorder treatment outcomes.
Farley et al. (2004) investigated the impact of trauma history on relapse and found that
probability of relapse increased in line with number of traumatic events experienced.
They also discovered that three specific types of traumatic event were associated with
relapse: mugging, seeing someone killed or seriously injured, and rape. Potential
limitations of this study were the use of trauma history rather than diagnosis of PTSD
and history of relapse being determined by retrospective reports of disengagement from
previous SUD treatments which does not take into account that individuals may not have
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attained abstinence whilst in these treatments, and therefore did not relapse but rather
simply failed to achieve abstinence. Despite these limitations, the findings have clinical
implications such as the need for early screening for trauma exposure and the need for
interventions which are trauma-informed.
Ouimette et al. (2007) investigated the relationship between relapse and comorbid SUD
and PTSD. This study aimed to build on previous findings that suggested that negative
emotions, physical discomfort and interpersonal conflict may be factors in relapse and
that PTSD is associated with fewer days of abstinence. Almost half of their sample met
criteria for PTSD and no difference in demographic variables or SUD diagnosis was
found between those with and those without PTSD. Participants with comorbid PTSD
and SUD were found to have significantly more interpersonal cues to drug use, stronger
urges to use substances, invested more effort in acquiring substances, were more likely
to consider their use was a 'relapse' rather than a lapse, and believed that they were at
greater risk of relapsing. These participants were less confident in their ability to handle
interpersonal conflicts and resist the urge to use substances. The authors proposed that
these findings supported the need for addressing self-efficacy and coping skills when
treating PTSD-SUD clients, particularly as interpersonal conflict may precipitate both
initial substance use and relapse. Self-efficacy may also be an important issue to
address as negative appraisals about the self being incompetent could maintain PTSD
symptoms and lead to relapse. However, the small sample size in this study (N = 65)
does make generalisation of these findings limited.
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Mills et al. (2007) also investigated the impact of PTSD on treatment outcomes for
heroin dependence in both injectors and non-injectors. Based on previous literature
suggesting that individuals with PTSD relapse to substance use more quickly, have
higher readmission rates, report more ongoing drug use, and evidence poorer
psychosocial outcomes, they conducted a longitudinal study of participants with heroin
dependence over a two year period. From their summation of the literature into long-
term outcomes, they concluded that individuals with comorbid PTSD and SUD had
more frequent and severe substance use, and were more likely to be readmitted to
treatment than those with SUD alone. The outcomes measured in their study were
retention in treatment for heroin dependence, subsequent treatment exposure, heroin and
other substance use, general physical and mental health, and employment status. No
significant difference in retention or completion rates, time spent in treatment or number
of treatment episodes was found between those with and those without current PTSD.
Similarly, no difference was observed with regard to heroin or other substance use
between groups, and those with PTSD were found to be less likely to be using heroin at
two year follow-up which is an unexpected finding. Both groups improved on all
domains and improved at the same rate, with the majority of improvement being made in
the first three months. However, there were some negative effects of current PTSD as
those with current PTSD were significantly less likely to be employed and experienced
significantly poorer physical and mental health.
One potential limitation of this study is the classification of 'current PTSD' being based
on having received a lifetime diagnosis and experiencing symptoms of the disorder in
47
the preceding twelve months. This may have meant that symptoms were not sufficient
to influence treatment outcome and some participants may not have met full criteria for
PTSD. Furthermore, there was no way to determine an association between severity of
PTSD symptoms and treatment outcome and some participants in the SUD only group
may have had subsyndromal PTSD which would in turn reduce the differences between
them and those with current PTSD. The study did not measure severity of substance use
on relapse and it is therefore not possible to determine if this is greater amongst those
with comorbid PTSD. The authors suggest that the impaired physical, psychosocial and
occupational functioning related to PTSD remains problematic for those in SUD
treatment which may be due to substance abuse treatment services producing
improvements in substance use and associated disability but not addressing the specific
symptoms and disability associated with PTSD. They therefore recommend combined
treatment approaches for PTSD and SUD as remission from PTSD is associated with
better SUD outcomes but remission from SUD has not been found to be associated with
improved PTSD outcomes (Cohen & Hien, 2006; Read etal., 2004).
Ouimette et al. (1997) conducted a one-year follow-up study investigating the impact of
PTSD on substance abuse treatment relative to those with substance abuse only or
substance abuse and another comorbid psychiatric diagnosis. The study had a large
sample (N = 3699) and female participants were excluded due to their comparatively
small numbers. All participants completed measures of substance use, psychological
symptoms, interpersonal supports, life stability, coping, and substance-related
cognitions. It was found that participants with substance abuse and PTSD improved on
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fewer outcome measures than those with substance abuse only or substance abuse and
psychiatric diagnosis. Furthermore, there was no difference between the substance
abuse and substance abuse-psychiatric group. The PTSD group also exhibited
significantly higher rates of negative consequences from substance use, psychological
problems, and unemployment and significantly lower rates of social support from
partners or friends. Those with PTSD-SUD were shown to be at greater risk of poorer
outcomes than SUD-only participants, as they used less positive reappraisal, more
cognitive avoidance and emotional discharge coping, more positive substance use
expectancies and less positive expectancies for staying abstinent. Individuals with
PTSD were also more likely to be readmitted to treatment than those with substance
abuse only however, it is possible that this was due to their mental health rather than
substance use, given that their rates of readmission were comparable with those with
comorbid substance abuse and other psychiatric diagnoses.
A further five-year follow-up study of one hundred male veterans addressed the
relationship between treatment and remission at five-year post-admission (Ouimette et
al., 2003). PTSD treatment and informal twelve-step self-help interventions in the first
year following intensive inpatient SUD treatment were predictive of remittance at five-
year follow-up but formal SUD continuing care treatment was not. It was also
discovered that earlier (within the first three months of SUD treatment) and longer
PTSD treatment was significantly associated with remission at five-years. These
findings do not support the view that individuals must attain a period of abstinence prior
to addressing PTSD symptoms (NICE, 2005). The positive effect of twelve-step self-
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help groups may also aid recovery from both SUD and PTSD as it focuses on providing
social support and positive associations with abstinence.
1.6.3.3 Effects ofTreatmentModality
There have been concerns raised that integrated treatments for PTSD and SUD, as
opposed to sequential treatment for each disorder, may lead to increase in psychiatric
symptoms such as anxiety and depression and this was investigated by Killeen et al.
(2008). Participants in their study were allocated to either a trauma-focused treatment
programme or a health education programme on women's reproductive health (which
did not address PTSD or trauma) and adverse events questionnaires were completed
prior to taking part in the study, on a weekly basis throughout the programme, and at
one-week post-intervention. 17% of participants reported study-related adverse effects
which involved worsening of PTSD symptoms or increased depression or anxiety as a
result of participating in either the trauma-focused treatment or health education
programme however, only 3% experienced study-related adverse effects that involved an
increase in substance use. Of those study-related adverse effects, 27% were classified as
'mild', 62% as 'moderate' and only 1% as 'severe' (which occurred in the health
education programme group). The more sessions a participant attended, the more study-
related adverse effects were experienced and it was proposed that this was likely to be an
artefact of the research process, given that there was more opportunity to report adverse
events. No difference was found between the extent of reporting of adverse effects for
the two groups which suggests that the trauma-focused intervention was tolerated by
participants.
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One limitation of this study is that it did not focus on outcome and it might have been
useful to investigate links between attendance, level of adverse events and outcome.
Another consideration is that the trauma-focused intervention did not include exposure
techniques and therefore these findings do not address concerns about interventions
which involve a trauma-processing component. However, as a first intervention, the
trauma-focused approach does appear to fit with the staged model of treatment for
trauma and SUD and the need to establish safety and coping skills prior to attempting
exposure work and processing of the traumatic material.
Cohen and Hien (2006) investigated the impact of complex PTSD and SUD on outcome
for a briefCBT intervention. The participants in the study were all women and 88% met
criteria for current PTSD, with the remainder having 'subthreshold' PTSD (presence of
DSM-IV criteria A, B, and E and either C or D). The study measured PTSD
symptomatology, substance use disorders, depression, dissociation, social and sexual
functioning. The CBT intervention led to a significant reduction in PTSD and alcohol
use disorder symptoms, and a trend towards a decrease in drug use disorder symptoms
however this was not significant. There was no effect on other symptoms and it was
suggested that future treatments would benefit from focusing on emotional dysregulation
and interpersonal problems to address the multiple comorbid conditions and difficult life
circumstances which are often present in individuals with complex PTSD and SUD.
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Somer (2003) addressed links between childhood trauma, dissociation and abstinence
from heroin use. The study compared a group of patients in an Israeli drug misuse
service with those in an outpatient stress clinic. It was hypothesised that childhood
abuse may lead to chronic autonomic arousal and difficulties in regulating affect. This
may then lead individuals to attempt "chemical dissociation" through the use of
substances or alternatively they may use substances to overcome psychic numbing and
satisfy a need for excitement. There was also a suggestion that oppressed survivors may
wish to defy authority and therefore engage in illicit drug use or due to their experiences
of abuse, may be more likely to seek out company in social groups where drug use is
common and therefore enables them to overcome feelings of isolation and loneliness. It
was found that individuals with more severe trauma histories had higher levels of
dissociation and heroin users who scored highly on the measure of dissociation were less
likely to obtain extended periods of abstinence. This led the author to recommend that
post-traumatic symptoms, particularly dissociation, should be addressed prior to the
expectation of abstinence.
1.7 Aim of Study
The main aim of the current study was to investigate the impact of comorbid PTSD and
SUD on factors affecting treatment compared to SUD alone. Factors investigated
included severity of dependence, trauma exposure, physical and psychological health,
risk-taking behaviour, and interpersonal functioning. Comorbidity of PTSD and SUD
has been shown in some studies to have an influence on treatment outcomes (e.g.
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Cocozza et a/., 2005; Hien et al., 2005; Mills etal., 2007; Ouimette et al., 2007). It was
therefore anticipated that the findings of this study would have implications for the
treatment of individuals with PTSD-SUD.
1.8 Hypotheses
Hypothesis 1: Higher levels of dependence on substances will be associated with higher
levels ofPTSD symptomatology.
Hypothesis 2: Higher number of types of trauma experienced will be associated with
higher levels of dependence on substances.
Hypothesis 3: Individuals with PTSD-SUD will have poorer physical and
psychological health than individuals with SUD alone.
Hypothesis 4: Individuals with PTSD-SUD are more likely to engage in risk-taking
behaviour than those with SUD alone.
Hypothesis 5: Individuals with PTSD-SUD will have higher levels of interpersonal




This study utilised a correlation design for hypotheses one and two, to investigate the
relationship between substance dependence and PTSD symptomatology and trauma. A
between-subjects design was employed for hypotheses three, four, and five to determine
differences in physical and psychological health, risk-taking behaviour, and
interpersonal conflict between those with PTSD and SUD and those with PTSD alone.
2.2 Ethical Approval
Ethical approval for the study was gained from the Lothian Local Research Ethics
Committee (see Appendix 1) and permission to conduct the study in an NHS site was
granted by the NHS Lothian Research & Development department (see Appendix 2).
2.2.1 Ethical Issues
The main ethical issue was that participants who were suffering from PTSD might
require debriefing following participation if they became distressed after being asked
about their experiences of trauma. This was addressed by offering participants a
debriefing session immediately after the measures were completed. Additionally,
participants were helped to access community supports. Participants also had support
available from their key worker. The researcher was available to discuss the potential
impact of PTSD on their drug use with the participant and their key worker if the
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participant wished to do so. Participants who met the criteria for moderate PTSD or
higher, as measured on the Posttraumatic Stress Diagnostic Scale, were offered a referral
to a clinical psychology service or other form of support which was appropriate to their
needs.
All potential participants were made aware of the nature of the study, a participant
information leaflet was provided (see Appendix 3) and a consent form was completed
(see Appendix 4). As some participants may have had difficulties with literacy, both the
participant information leaflet and consent form were read aloud and explained to all
participants.
As there was a small risk of injury or distress if participants became distressed, the
researcher attended the NHS Lothian mandatory Management of Violence and
Aggression Course. Personal alarms were available at the community drug problems
centre and this was worn by the researcher as a further safety precaution.
The ethics process also requires that potential benefits to participants be considered.
This prevalence study was of potential direct benefit to the participants as routine
screening for Post-Traumatic Stress Disorder (PTSD) for injecting drug users in the City
of Edinburgh area is not currently in place. More generally, it was hoped that
participants and other service users would benefit from the findings of this study as it led
to the identification of the level of co-occurring PTSD and substance use disorder
(SUD). This may lead to routine screening in the population and, where identified,
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integrated treatment for PTSD and SUD. As integrated treatment of PTSD and SUD
leads to greater treatment gains than treating the conditions sequentially or neglecting to
treat one condition (Cocozza et al., 2005; Morrissey et al., 2005), a move towards
integrated treatment would be of benefit to service users. Participants were also made
aware that their current treatment would not be affected if they declined to participate in
the study.
Secondary traumatisation of the researcher was considered as a further ethical
consideration. This was addressed by the researcher having regular clinical supervision
with a chartered clinical psychologist to discuss any difficulties arising from hearing
details ofparticipants' traumatic experiences.
2.3 Participants
Participants were injecting drug users who were identified when they attended the Low
Threshold Methadone Programme (LTMP) at a harm reduction service as weekly or
daily clients or when they attended the Community Drug Problem Service (CDPS) for
methadone maintenance or opiate substitution treatment. Participants were also
recruited from abstinence-based programmes which provided support in the form of a
key worker. Individuals who used other services at the harm reduction service, such as
the Needle Exchange, who were not on a methadone maintenance prescription or
equivalent treatment were not considered for inclusion in this study as it was felt that
they may not have access to sufficient support and therefore to enquire about trauma in
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this population could be detrimental to their mental health. All participants were
between 16 and 65 years of age. Potential participants were excluded from the study if:
(i) they presented with a psychotic illness, brain damage or other organic impairment; or
(ii) if they had a serious medical illness requiring inpatient treatment; or (iii) if they had
expressed suicidal or homicidal thoughts.
2.4 Procedure
Participants were drawn from a community sample of injecting drug users who were
enrolled on a treatment programme in the NHS Lothian area. The treatment received by
these clients was either the prescription of an opiate substitute or an abstinence-based
model of treatment. Information about this study including the participant information
leaflet was disseminated by the Nurse Manager to the team leaders of the locality teams
in the community drug problems service. This was followed up by the researcher
meeting with the staff groups at their team meetings to present the rationale for the study
and answer any questions. Staff members of the Low Threshold Methadone Programme
(LTMP) and the pharmacist responsible for the methadone titration clinic were also
contacted by the researcher directly at a team meeting. Potential participants were
initially approached via their key worker who gave them a copy of the participant
information leaflet, thus all participants in the study had a substance misuse key worker.
Recruitment of participants was then followed up by contacting key workers by
telephone to arrange suitable times to recruit from their clinics. The participants had at
least twenty-four hours in which to decide whether or not to participate in the study after
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receiving the information leaflet from their key worker. Participants were then recruited
following a briefmeeting (no longer than 5 minutes) with the researcher to discuss the
rationale for the study, confidentiality and what participation in the study would involve.
They were made aware of their right to withdraw from the study at any time and were
given the opportunity to ask any questions about the study.
Participants who agreed to take part were given an appointment to complete the
measures with the researcher. The measures were administered by the researcher in a
clinic room in the main community drug problem service clinic or the participants' local
clinic. Prior to completing the measures, the researcher checked that the participant had
read and understood the participant information leaflet and gave them the opportunity to
answer any questions about the project and outlined the bounds of confidentiality
relating to the study. The consent form was then read aloud to the participant and they
were asked to initial the boxes to indicate that they had understood the issues relating to
their participation and then sign and date the form. The researcher then signed and dated
her section of the consent form and a copy was given to the participant to keep. Due to
resource implications, interpreters would only have been requested for participants who
did not speak English or who used British Sign Language if it was part of their routine
clinical care.
The three questionnaires were completed by the participant and the researcher in
interview format, with each item read aloud to the participant and responses recorded on
the corresponding response sheet. For items which used a Likert-type scale, the options
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were explained to the participant and a card was presented with the responses for these
items or subscales to aid the participants in choosing their response. The measures used
were the Maudsley Addiction Profile (MAP), the Leeds Dependency Questionnaire
(LDQ), and the Posttraumatic Stress Diagnostic Scale (PDS). As the MAP contains a
section on demographics, this measure was completed first and took around ten to
fifteen minutes. The second measure completed was the LDQ which took less than five
minutes to complete and the final measure was the PDS which took between ten and
fifteen minutes to complete. An hour was scheduled for each participant, with the
measures taking approximately thirty to forty minutes to complete and the remaining
time allowed for debriefing and arrangements for further support to be arranged if
required.
A resource pack was also available for key workers which contained contact
information for local agencies which could offer further support. Participants who were
found to meet the criteria for Post-Traumatic Stress Disorder were also offered a referral
to clinical psychology or another agency which was appropriate to their needs and their
key workers were made aware of this information, with the participants' consent.
Following data collection, all identifying information was removed and each participant
was allocated a code prior to data analysis.
2.5 Measures
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All participants completed three validated measures to yield information relating to the
key aims of the study. These measures were chosen as they are standardised and are
relatively quick to administer.
2.5.1 The Maudsley Addiction Profile (MAP)
This is a brief, multi-dimensional measure of treatment outcome for individuals with
substance use disorders (Marsden et ah, 1998; see Appendix 5). The average
administration time is around twelve minutes and it is relatively quick to score. It has an
introductory section which is adapted to suit local research needs and assesses four
domains which have been shown to have associations with both diagnosis ofPTSD and
with likelihood of success in treatments for drug use. Exploratory principal components
analysis identified four factors which accounted for 63% of the variance in scores: the
substance use, health risk, health problems and employment (a sub-section of personal
and social functioning) domains (Mardsen et ah, 1998). These domains were found to
be statistically independent, however the crime subsection of the personal and social
functioning domain was also found to be linked to the substance use factor. However,
this does not necessarily mean that these factors lack discriminant validity.
The introductory section is used to record demographic data: sex, age, time in current
treatment, age when first used substances, and number of previous contacts with drug
problem services. The remainder of the measure comprises sixty items in four domains
which are outlined below.
60
2.5.1.1 Substance Use domain
The substance use subscale records the frequency, amount and route of administration of
alcohol and illicit substances in the thirty days preceding the interview. There are seven
named substances - heroin, non-prescribed methadone, illicit benzodiazepines, cocaine
powder (cocaine hydrochloride), crack (cocaine base), amphetamine, and cannabis -
with space for additional substances to be added (e.g. MDMA/'Ecstasy' or GHB).
Participants indicate the route of administration of each substance as being oral,
intranasal, inhalation, intravenous or intramuscular. A response card is shown to
participants to help them rate the frequency of their use over the past week and route of
administration (see Appendix 6). The substance use subscale was found to have
excellent concurrent validity for self-reported drug use when compared with the result of
a urine drug screening test, where Cohen's kappa (k) was 0.74 for heroin, 0.65 for
methadone, 0.76 for cocaine and 0.79 for benzodiazepines (Marsden etal., 1998).
2.5.1.2 Health Risk domain
The health risk subscale has five items which address injecting behaviour and sexual
activity, which are routes of transmission for blood bome vimses such as HTV and
Hepatitis C. It contains items which look at frequency of injecting and sharing needles.
There is also an item which records number of sexual partners and frequency of condom
use in the past thirty days. Marsden et al. (1998) found that the three day test-retest
reliability for this subscale indicated that the reliability is extremely high for frequency
of sharing needles (k = 0.97), for number of sexual partners (k = 0.92), and for frequency
of unprotected sex (k = 0.88).
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2.5.1.3 Physical and Psychological Health domain
This domain has twenty items and is divided into two subscales. The physical health
symptom scale has ten items reflecting five functional systems: general, injection-
related, gastro-intestinal, cardiovascular, musculo-skeletal, and neurological. The ten
items form five pairs corresponding to each of these five areas. The psychological
health symptoms scale also has ten items: five each assessing anxiety and depression.
These items are rated on a five-point Likert scale from 'never' to 'always' and a card is
presented to enable participants to select their response (see Appendix 6).
Psychometric properties of this subscale have been described by Marsden et al. (1998).
Internal reliability of the physical health scale was satisfactory (a - 0.77) while the
internal reliability of the anxiety and depression scales were good (a = 0.88 and a = 0.81
respectively). Criterion validity of this subscale was assessed by comparing the number
of self-reported days where the client experienced medical or mental health (anxiety and
depression) symptoms in the previous month with responses to the Addiction Severity
Index medical and psychiatric composite scores (ASI; McLellan et al., 1992). The
physical health symptom scale and days with medical symptoms indicated excellent
concurrent validity (r - 0.74, p <0.0001). The psychological health symptom scale also
showed very good concurrent validity as the number of days where participants reported
anxious thoughts or depressive thoughts correlated highly with anxiety and depression
scores (r = 0.73, p <0.0001 and r = 0.69,p <0.0001 respectively).
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2.5.1.4 Personal and Social Functioning domain
This subscale comprises ten items which focus on relationship problems, employment
and illegal activity. Frequency of contact with partners, relatives and friends is recorded
as is the frequency of conflict with each of these groups in the preceding month. The
concurrent validity of the measure of relationship conflict was assessed by comparing
the items with the relationship stressors subscale of the Adult Form of the Life Stressors
and Social Resources Inventory (LISRES; Moos, 1988). The correlations between the
LISRES scales and the partner stressors and conflict scores (r = 0.76, p <0.0001);
relatives stressors and conflict scores (r = 0.77, p <0.0001); and friends stressors and
conflict scores (r = 0.70, p <0.0001) indicated that concurrent validity was high
(Marsden etal., 1998).
Participants are also asked to report how many days they spent in formal employment,
absent from work or unemployed in the past month. The final section requires the
nature of crimes committed in the past thirty days to be recorded: selling drugs,
fraud/robbery, shoplifting, theft from a property, theft from a vehicle, theft of a vehicle,
other crimes e.g. selling sex. The test-retest reliability for items relating to employment
(k = 0.99 for days worked; k = 0.98 for work absences; k = 0.89 for unemployment) and
crime (k - 0.94 for selling drugs; k = 0.89 for shoplifting; k = 0.85 for other crimes
including theft from a property, theft from a person, theft from or of a vehicle, and
fraud/forgery) was also very high.
2.5.1.5 Other Measures ofTreatment Outcome
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Other tools which also aim to provide a measure of treatment outcome in a range of
areas (such as substance use, medical and psychiatric status, health risk behaviour,
interpersonal functioning, employment and criminality) for substance using populations
were also considered. These included the Addiction Severity Index - 5th Edition (ASI;
McLellan et al., 1992), the Christo Inventory for Substance-misuse Services (CISS;
Christo, Spurred & Alcorn, 2000), and the Opiate Treatment Index (OTI; Darke et al.,
1991). These measures were considered less suitable for the purposes of this study than
the MAP for the reasons outlined below.
Makela (2004) outlines a number of limitations of the ASI, including that it performs
poorly in European settings, that severity ratings should not be used for research
purposes as low correlations between severity scores and composite scores for the same
problem area indicates unstable concurrent validity, and that several studies have
reported low internal consistencies in four of the seven composite scores. This lack of
consistency is due in part to the subjective nature of the ratings given by respondents and
this is a major weakness of the measure (Darke et al., 1992). Furthermore it has been
shown that the ASI is not sufficiently reliable in detecting psychiatric symptoms,
particularly with respect to anxiety and depression (Cacciola et al., 1999; Currie et al.,
2004). The administration time for the ASI is one hour and a two-day training session
should be completed prior to researchers or clinicians using this tool. Given these
limitations and time demands, the MAP was deemed a more appropriate tool for the
purposes of this study.
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The CISS is a briefer interviewer rated screening tool developed for audit purposes. It
does not address health status, drug-taking behaviour or interpersonal relationships in
any detail and thus provides insufficient information to be of value in this study. Indeed
the author of the CISS recommends that it is not used for research purposes (Effective
Interventions Unit, 2003). The OTI was also considered and whilst it provided a good
overall profile of relevant areas which were looked at in this study and has excellent
psychometric properties, the MAP was chosen over this measure. This was due to the
OTI taking twice as long to administer (approximately thirty minutes) as the MAP, and
because the OTI uses a somewhat less accurate method for calculating substance use
(average over previous three episodes of use), records episodes of conflict with no
comparison to episodes of contact with conflict to determine quality of relationship, and
a dichotomous scale for recording health problems.
2.5.2 Leeds Dependence Questionnaire (LDQ)
This is a ten-item self-completion questionnaire designed to measure severity of
dependence on a variety of substances (Raistrick et al., 1994; see Appendix 7). The
items are scored on four-point Likert scales from 'never' to 'nearly always' and yield a
maximum score of 30. The measure has ten markers of substance dependence which are
each accounted for by a single item in the LDQ. These ten markers are pre-occupation,
salience of substance use, compulsion to start, planning around substance use, maximise
effect, narrowing of use repertoire, compulsion to continue, primacy of effect, constant
state, and cognitive set. The markers aim to measure the same phenomena as outlined in
the ICD-10 (World Health Organisation, 1992), but also map onto the seven criteria for
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substance dependence outlined in the DSM-IV (APA, 1994). The LDQ has been shown
to have good internal reliability for a sample of opiate users (a = 0.86; Heather et al.,
2001) and good sensitivity, concurrent and convergent validity when used in a sample of
drug users with comorbid psychiatric diagnoses (Ford, 1993). In addition to good
psychometric properties, norms have been published for users of opioids indicating mild,
moderate or severe severity (Heather et al., 2001) which allows individuals to be
categorised in this way.
2.5.2.1 Other Measures ofSeverity
Heather et al. (2001) suggested that the Severity of Dependence Scale (SDS; Gossop et
al., 1995) may be more useful as a screen for research purposes where a basic measure
of dependence is sufficient. However, Gossop et al. (1995) reported from their study of
the reliability and validity of the SDS that it provides a measure of compulsive drug use
rather than a broader measure of dependence. It therefore seemed that the LDQ would
provide a more useful measure for this study as it addresses other factors associated with
substance dependence such as withdrawal, tolerance and reinstatement.
Another potential measure of dependency is the Substance Dependence Severity Scale
(SDSS; Miele et al., 2000a), which is based on the DSM-IV dependence criteria and
takes between 30 and 45 minutes to complete, depending on whether an abridged
version is used and whether the respondent has polydrug use. It is reported to have good
internal consistency and convergent and discriminant validity as indicated by
correlations with severity scores which are derived from the ASI composite scales for
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alcohol, heroin and cocaine use (Miele et al., 2000b). It offers two measures of
dependency - frequency and severity of symptoms, but norms are not available for drug-
specific samples. Given the time taken to administer this measure and the lack of norms
available, the LDQ was thought to be a more useful measure of dependence.
2.5.3 Posttraumatic Stress Diagnostic Scale (PDS)
This is a 49-item measure which can be used to diagnose post-traumatic stress disorder
(PTSD), severity ofPTSD and level of functional impairment (Foa, 1995; see Appendix
8). It is based on the DSM-IV diagnostic criteria for PTSD (American Psychiatric
Association, 1994; see Appendix 9). The measure comprises three parts which are
divided by the DSM-IV criteria. The first part asks the participant to endorse traumatic
event(s) that they have either experienced or witnessed. The second part asks the
participant to describe which traumatic event was most upsetting for them, the length of
time elapsed since the event, whether they or someone else suffered physical harm and
whether they thought their own or another person's life was in danger at the time of the
event. The third part assesses whether the respondent is re-experiencing the event; has
symptoms of avoidance or numbing; or increased levels of arousal. A diagnosis of
PTSD can only be made if all six of the DSM-IV criteria are met. The duration of
symptoms and degree of impairment in functioning is also recorded. Severity of
symptoms, which is rated on a four-point Likert scale, gives rise to four categories
ranging from 'mild' to 'severe'. The PDS takes around 20 minutes to complete and is
relatively quick to score.
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The PDS has been reported to have a high internal consistency, with each of the three
symptom clusters measuring a unified construct (Foa et al., 1997). In their 1997 study,
Foa et al. found that overall symptom severity had the highest reliability (a = 0.92)
followed by avoidance, arousal and re-experiencing where a = 0.84, a = 0.84, and a =
0.78 respectively. The measure was also found to have high test-retest reliability with
percentage agreement after a 2-3 week interval of 87% (k — 0.74). Convergent validity
of the PTSD diagnoses was determined by comparing them with diagnoses identified by
the Structured Clinical Interview for the DSM-III-R (SCID; Spitzer et al., 1990) which
indicated 82% agreement between measures (k = 0.65). Sensitivity of the PDS was 89%
and specificity was 75%.
Foa et al. (1997) assessed concurrent validity by performing Pearson correlation
coefficients between the PDS and the Impact ofEvents Scale - Revised (IES-R; Weiss &
Marmar, 1997), Beck Depression Inventory (BDI; Beck et al., 1961), and the State-Trait
Anxiety Inventory (STAI; Spielberger et al., 1970). Overall, higher PTSD severity and
symptom cluster scores were associated with higher IES-R, BDI and STAI scores. The
correlation between the PDS total symptoms severity was similar for both the BDI (r =
0.79) and IES-R (r = 0.78). It was slightly lower for correlations with the STAI State (r
= 0.73) and STAI Trait scores (r = 0.74). The PDS re-experiencing score correlated
more highly with the IES-R intrusion score (r = 0.77) than the avoidance score (r = 0.72)
which was significant /(227) = 2.10, p <0.05. The PDS avoidance score was also
correlated more highly with the IES-R avoidance score (r = 0.69) than the re-
experiencing score (r = 0.51), t(221) = 4.97, p <0.001. This suggests that the re-
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experiencing and avoidance subscales of the PDS are valid and the high correlation of
the arousal subscale with both state and trait anxiety measures on the STAI (r = 0.70)
also lends support to the validity of this symptom cluster.
2.5.3.1 Other Measures ofPost Traumatic Stress Disorder
The PTSD Symptom Scale (PSS; Foa et ah, 1993) was published before the PDS and is
available in two versions - an interview version (PSS-I) and a self-report version (PSS-
SR). Foa et ah (1993) found the PSS-I to be a more sensitive measure of PTSD
diagnosis than the PSS-SR, but both were found to be internally consistent and valid
measures of PTSD symptom severity. Furthermore, a modified version of the PSS-SR
(MPSS-SR; Falsetti et ah, 1993) has been shown to be a useful screening tool for PTSD
within a substance use disorder (SUD) population (Coffey et ah, 1998). Foa & Tolin
(2000) have also proposed that the PSS-I is an acceptable alternative to the Clinician-
Administered PTSD Scale (CAPS; Blake et ah, 1990) which is widely accepted as the
"gold standard" measure of PTSD. Although it is deemed to be the gold standard, the
CAPS was not considered for use in this study as it takes forty-five minutes to one hour
to administer.
It is worth noting that both the PSS-I and the PSS-SR were both developed to have good
convergent validity with the DSM-III-R criteria for PTSD (Foa et ah, 1993). The PDS,
on the other hand, is based on the DSM-IV criteria for PTSD. There are some changes
between these sets of criteria which change the construct of PTSD to some extent. The
main difference relates to Criterion A which in DSM-III-R requires that an event be
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'outside the range of usual human experience and that would be distressing to almost
anyone' (American Psychiatric Association, 1987). In the DSM-IV, two features of a
traumatic event must be present to meet this criterion. Firstly, that the person witnessed
or experienced serious injury to self or others, the threat of death or serious injury to self
of others, or death or threat to physical integrity of others. The second feature is that the
person's response must have involved 'intense fear, helplessness or horror' (American
Psychiatric Association, 1994). One key area which other scales failed to address
adequately (if at all) was information about the event which caused the post-traumatic
symptoms (i.e. Criterion A) or interference with daily functioning (Criterion F). The
PDS was developed in order to address these gaps (Foa et al, 1997).
Wohlfarth et al (2003) reported that a comparison of IES and PDS indicated that either
could be used as a screen for PTSD, as the EES had a slightly higher sensitivity and the
PDS had a slightly higher specificity but overall the measures were comparable.
Creamer et al. (2003) investigated the reliability and concurrent validity of the Impact of
Events Scale-Revised (IES-R; Weiss & Marmar, 1997) by determining the correlations
with the subscales of the PTSD Checklist (PCL; Weathers et al, 1993). Their study
indicated that the reliability and validity of the IES-R appears to equal, if not surpass, the
PDS but state that the primary disadvantage of the scale is that the items are not derived
from the DSM-TV criteria. It also lacks the additional features of an arousal subscale
and a measure of functional impairment. For this reason the PDS was selected as the
measure ofPTSD over the IES-R.
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2.6 Power and Sample Size
2.6.1 Hypotheses 1 and 2
Sample size was determined from Cohen (1992) which indicated that a sample size of 30
participants would be required to detect a large effect size (0.35) with an alpha value of
0.05 and power at 0.80.
2.6.2 Hypotheses 3, 4 and 5
A sample size of 52 (26 in each group) was calculated as being required for the three
hypotheses which require comparisons of independent sample means (Cohen, 1992).
This would detect a large effect size (0.80) with an alpha value of 0.05 and power at
0.80.
2.7 Statistical Analysis
The data were analysed using Pearson's correlational analysis to address hypotheses one
and two. Student t-tests were used to analyse the data for the third hypothesis and the





The sample comprised 30 injecting drug users with a mean age of 33.1 years (S.D. = 7.9;
range = 19-50), twenty-four (80% of the sample) were male and six (20%) were female.
43.3% (N = 13) of the sample reported being in a relationship and the remainder
reported being single. The main source of income was disability or unemployment
benefit and 96.7% (N = 29) of the sample were formally unemployed. Reported mean
length of drug use was 9.1 years (S.D. = 5.9; range 2-27) and 60% (N - 18) of the
sample had previously received treatment for their substance use disorder. The mean
length of time in current treatment was 540 days (S .D. = 1095; range = 1-5760). Despite
being in substance misuse treatment, 50% (N= 15) of the participants reported that they
had injected heroin at least once in the previous month and 23.3% (N = 7) admitted to
engaging in criminal activities.
As potential participants were invited to take part in the study by their key workers, who
were given copies of the participant information leaflet (see Appendix 3) at their team
meeting or via email from the researcher or their team leader, it was difficult to
determine how many people were invited to participate in the study in total. Of those
who were approached by their key worker and agreed to participate in the study, 43
(58.9%) either later decided not to take part, or were unable to agree a mutually suitable
time to meet with the researcher, or failed to attend their meeting with the researcher to
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complete the measures. It is unknown how many people were approached by their key
worker and declined to take part in the study. It wasn't possible to collect demographic
or other data directly regarding those who chose not to take part.
3.2 Descriptive statistics
A descriptive account of the range for each measure or subscale is provided below with
the corresponding means and standard deviations. A summary of the means and
standard deviations are presented in Table 3.1.
Table 3.1 Summary of Mean Scores ori Main Measures 1 (N = 30)
Mean Std. Deviation
LDQ 11.3 7.8
PDS - Symptom severity 26.5 13.1
PDS - Number of traumas 4.8 2.6
MAP - Physical Health 16.8 8.1
5MAP - Psychological Health 20.8 9.5
MAP - Risk Behaviour 1.2 2.7
MAP - Interpersonal Conflict 4.2 8.7
LDQ: Leeds Dependence Questionnaire; PDS: Posttraumatic Stress Diagnostic Scale; MAP: Maudsiey Addiction
Profile
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3.2.1 Leeds Dependence Questionnaire (LDQ)
The LDQ is a measure of global dependence and the overall score is the sum of
responses to ten items, tapping ten aspects of substance dependency. The mean for the
LDQ was 11.3 (S.D. = 7.84; range = 0-27) which falls within the 'mild' range of opiate
dependence. Overall, 73.3% per cent of participants had 'mild' dependence (N = 22),
16.7% had 'moderate' dependence (TV = 5), and 10% had 'severe' dependence (N = 3)
according to the norms given by Heather et al. (2001).
3.2.2 Posttraumatic Stress Diagnostic Scale (PDS)
The PDS is designed to assess each of the DSM-IV criteria for Post Traumatic Stress
Disorder. The two measures of interest to this study were Part 2, which looks at
exposure to traumatic events (Criterion A) and Part 3 which measures PTSD
symptomatology (Criteria B-D: Re-experiencing, Avoidance, and Arousal).
3.2.2.1 Symptom Severity
PTSD symptom severity was determined by the frequency of endorsement of each
symptom occurring during the previous month. The mean score on the symptom
severity measure was 26.5 (S.D. = 13.1; range = 0-48) which indicates 'moderate-to-
severe' PTSD symptom severity. These scores indicated that 10% (N= 3) of the sample
had no or 'mild' symptoms of PTSD, 30% (N= 9) had 'moderate' symptoms, 23.3% (N
= 7) had 'moderate-to-severe' symptoms, and 36.7% (N= 11) had 'severe' symptoms of
PTSD.
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The group of participants who met full diagnostic criteria for PTSD (N= 19) had a mean
symptom severity score of 32.4 (S.D. = 10.7; range = 11-48) which falls within the
'moderate-to-severe' range of severity and those who did not meet full criteria for PTSD
(N = 11) had a mean symptom severity score of 16.3 (S.D. = 10.6; range = 0-31) which
falls within the 'moderate' range.
3.2.2.2 Number of Traumatic Events
The mean number of traumatic events experienced or witnessed by participants was 4.8
(S.D. = 2.6; range = 0-10). The number (and percentage) of each participant reporting
each event is shown in Table 3.2 along with the most traumatic event, which is the event
that the participants gave as the most distressing event ofall those they had experienced.
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Table 3.2 Causes of Trauma and Most Traumatic Events




Accident or fire 13 (43.3) 0 (0.0)
Natural disaster 0 (0.0) 0 (0.0)
Nonsexual assault (known assailant) 17(56.7) 6 (20.7)
Nonsexual assault (unknown assailant) 18 (60.0) 2 (6.9)
Sexual assault (known assailant) 10(33.3) 1 (3.5)
Sexual assault (unknown assailant) 5 (16.7) 0 (0.0)
Combat or war zone 2 (6.7) 1 (3.5)
Sexual abuse 14(46.7) 2 (6.9)
Imprisonment 17(56.7) 3 (10.3)
Torture 9(30.0) 2(6.9)
Life-threatening illness 9(30.0) 0 (0.0)
Other 19(63.3) 12(41.3)
None 1 (3.3) N/A
Non-sexual assault by a known assailant was the type of trauma that was most
frequently reported as being the most traumatic of all events experienced (20.7% of the
sample), followed by traumatic bereavement (13.8%), imprisonment (10.3%), childhood
sexual abuse (6.9%), traumatic separation from a parent (6.9%), non-sexual assault by a
stranger (6.9%), torture (6.9%), and witnessing a murder (6.9%). The remaining
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categories of being held hostage, sexual assault by a known assailant, attempted murder,
combat, overdose, and running away from a care home in childhood were each endorsed
by a single participant and comprised the remaining 20.7% of the sample.
3.2.3 Maudsley Addiction Profile (MAP)
3.2.3.1 PhysicalHealth
Participants' scores of the physical health subscale of the MAP had a mean of 16.8 (S.D.
= 8.1; range = 1-30). No norms were available to indicate levels of severity within this
subscale. However, the MAP pilot study conducted by Marsden et al. (1998) found that
for a sample of community drug users the mean physical health score was 14.9 (S.D. =
6.9) suggesting that the current sample may be representative of injecting drug users in
community settings, although the current sample did have slightly poorer physical health
than Marsden et al. 's pilot sample as indicated by the higher mean score.
3.2.3.2 PsychologicalHealth
The psychological health subscale of the MAP had a mean of 20.8 (S.D. = 9.5; range =
0-36). Again, no norms were available to determine levels of severity and the mean
score for the MAP pilot was 16.6 (S.D. = 8.7) which indicated less frequent
psychological health problems than the current sample.
3.2.3.3 Risk-taking Behaviour
The mean number of reported incidents of blood bome virus (BBV) risk-taking
behaviour within the past 30 days was 2.3 (S.D. = 5.9; range = 0-30). With respect to
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these behaviours, eleven participants (36.7%) reported having penetrative sex without a
condom in the past month which resulted in sixty-seven episodes of unprotected sex.
One participant (3.3%) reported that they had used injecting equipment previously used
by another person on two occasions. In total, there were sixty-nine recorded episodes of
BBV risk-taking episodes in the current sample. In addition to these BBV risk
behaviours, half of the sample reported injecting heroin on at least one occasion
resulting in a mean injecting score of 19.1 (S.D. = 37.6; range = 0-180) and there were
583 reported episodes of injecting drug use in the sample. However, as these individuals
were not reporting sharing their equipment, they were not included in the BBV risk
group.
3.2.3.4 Interpersonal Conflict
The mean number of reported incidents of interpersonal conflict within the past 30 days
was 4.2 (S.D. = 8.7; range = 0-34). Of the total sample, twelve participants (40%)
reported episodes of interpersonal conflict, seventeen (57%) reported no episodes of
interpersonal conflict, and one did not have any interpersonal contact with a partner,
relatives or friends in the past 30 days. Thirteen participants reported having contact
with a partner during the preceding month and seven (54%) reported that this contact
resulted in conflict on at least one occasion. Twenty-three participants reported having
contact with relatives, which resulted in conflict for six of the participants (26%) and
twenty-one reported having contact with friends, with six reporting conflict (29%).
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3.3 Inferential Statistics
3.3.1 Hypothesis 1: Higher levels of dependence on substances will be associated
with higher levels ofPTSD symptomatology.
To test this hypothesis, a correlational analysis was conducted. Pearson's correlation
was used as although the dependency data appeared to have a slight positive skew
further investigation using Shapiro-Wilk's test indicated that it did not to deviate
significantly from the normal distribution (p = 0.24, n.s.). Similarly, the PTSD data
appeared to have a slight negative skew and the Shapiro Wilk's test indicated that it did
not deviate significantly from the normal distribution (p = 0.23, n.s.). A positive
correlation was found between these two variables, indicating that individuals with
higher levels of dependency also had higher levels ofPTSD symptomatology (r = 0.59,
p = 0.01, TV = 30). These findings are shown in Table 3.3 below.
3.3.2 Hypothesis 2: Higher number of types of trauma experienced will be associated
with higher levels ofdependence on substances.
A Pearson's correlation was conducted to investigate the relationship between the
number of traumas experienced and severity of substance dependence as the
distributions did not deviate significantly from the normal distribution. A significant
relationship was found between number of traumas experienced and severity of
substance use (r = 0.32, p = 0.04, N = 30), where individuals who had experienced a
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higher number of types of traumatic events had higher levels of dependence on
substances (see Table 3.3).
3.3.3 Hypothesis 3: Individuals with PTSD-SUD will have poorer physical and
psychological health than individuals with SUD alone.
Individuals who met full diagnostic criteria for PTSD were placed in the 'PTSD-SUD'
group (TV = 19) and those who met partial or no criteria for PTSD were assigned to the
'SUD only' group (TV = 11). The mean physical health score for the PTSD-SUD group
was 18.6 (S.D. = 7.5; range = 7-30) and the mean physical health score for the SUD only
group was 14.1 (S.D. = 8.6; range 1-25), indicating poorer physical health in the PTSD-
SUD group. As the data were normally distributed, a t-test for independent samples was
used. The results approached, but did not reach, significance (t (28) = 1.43, p = 0.08,
n.s., one-tailed) and so the null hypothesis could not be rejected.
To determine if there was a significant difference between psychological health ratings
between the two groups, another independent samples t-test was conducted. The mean
for the PTSD-SUD group was 23.1 (S.D. = 8.6; range = 3-36) and the mean for the SUD
only group was 16.8 (S.D. = 10.1; range = 0-32), indicating poorer psychological health
in the PTSD-SUD group. There was a significant difference in psychological health
between those with PTSD and SUD and those who had SUD alone (t (28) = 1. 81,/? =
0.04, one-tailed). These results therefore indicated that individuals who had PTSD-SUD
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had significantly higher levels of psychological distress than those with SUD alone.
Therefore the hypothesis was supported with regards to psychological health, but was
only approaching significance in terms of physical health.
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3.3.4 Hypothesis 4: Individuals with PTSD-SUD are more likely to engage in risk-
taking behaviour than those with SUD alone.
The data for risk-taking behaviour was strongly positively skewed, therefore a Mann-
Whitney U test was used to analyse the data. The median number of risk taking
behaviours in the preceding 30 days was 0, with an interquartile range of 0 to 2.0.
Individuals with comorbid PTSD and SUD were significantly more likely to participate
in behaviours which place them at risk of contracting blood bome viruses than
individuals with SUD alone as U = 68.5, p = 0.04 (one-tailed). The hypothesis is
therefore supported by these findings.
Due to the high number of participants in both groups reporting no episodes of risk-
taking behaviour, further analysis was conducted using a 2 x 2 chi-square to determine if
there was a significant relationship between having a diagnosis ofPTSD and engaging in
risk-taking behaviours (see Table 3.4 below). A significant relationship was found
between having a diagnosis of PTSD and engaging in risk-taking behaviour (x (1) =
2.56, p = 0.05) and Cramer's V was 0.29, indicating that approximately 8% of the
variance in the frequencies of risk-taking behaviour can be explained by the presence of
PTSD.
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Table 3.4 Relationship between PTSD and Risk-taking behaviour
PTSD NoPTSD
Engaged in Risk-taking 9 2
No Risk-taking 10 9
3.3.5 Hypothesis 5: Individuals with PTSD-SUD will have higher levels of
interpersonal conflict than those with SUD alone.
The data for interpersonal conflict scores were strongly positively skewed (did not meet
the requirements for normal distribution) and were analysed using the Mann-Whitney U
test The median number of episodes of interpersonal conflict was 0 and the
interquartile range was 0 to 3.5. There was no significant difference between the levels
of interpersonal conflict experienced by those with comorbid PTSD and SUD and those
with SUD alone as U = 81, p = 0.13 (one-tailed). Thus the hypothesis that individuals
with comorbid PTSD-SUD will experience higher levels of interpersonal conflict was
not supported.
The relationship between having a diagnosis of PTSD and experience of interpersonal
conflict was also explored using 2x2 chi-square analysis as a high number of
participants reported no experience of interpersonal conflict (see Table 3.5 below). This
did not show any significant relationship between diagnosis of PTSD and likelihood of
experiencing an episode of interpersonal conflict (%2 (1) = 0.34, p = 0.56, n.s.).
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Table 3.5 Relationship between PTSD and Interpersonal conflict
PTSD No PTSD
Experienced Conflict 9 4
No Conflict 10 7
3.4 Exploratory Analyses
3.4.1 Severity ofDependence
Further analyses were conducted to determine if severity of dependence on substances
was significantly related to other factors such as physical and mental health, risk-taking
behaviour, and interpersonal conflict.
3.4.1.1 Dependence and Health
Pearson's r was used to determine if there was a significant correlation between severity
of substance dependence and either physical or psychological health. There was no
significant association between physical health and severity of substance dependence (r
= 0.17, p = 0.19, n.s., N = 30), but there was a positive significant association between
severity of substance dependence and psychological distress (r = 0.52, p < 0.01,N= 30).
3.4.1.2 Dependence andRisk
The relationship between severity of dependence and risk-taking behaviour was
explored using Spearman's correlation, as the data set for risk-taking behaviour was
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highly skewed. No significant relationship between severity of dependence on
substances and risk-taking behaviour was found (rs = 0.09, p = 0.62, n.s., N= 30).
Due to number of participants who reported engaging in no blood bome virus risk
behaviours, the data were dichotomised into two groups 'risk' (reported one or more
episodes of risk-taking behaviour in the previous 30 days; iV =11) and 'no risk' group
(reported no episodes of risk-taking behaviour in the previous 30 days; N = 19). The
mean score for the 'risk' group was 12.5 (S.D. = 8.7; range = 1-27) and the mean score
for the 'no risk' group was 10.6 (S.D. = 7.4; range = 0-24), indicating higher mean
dependence scores in the 'risk' group. A t-test indicated that there was no significant
difference in severity of drug dependence between those who reported engaging in
behaviours which placed them at risk of acquiring a blood bome virus and those who
reported not engaging in these behaviours (t (28) = 0.65, p = 0.52, n.s.).
3.4.1.3 Dependence and Conflict
A positive relationship between severity of substance dependence and experience of
interpersonal conflict was explored using Spearman's correlation. Higher levels of
dependency were associated with higher levels of interpersonal conflict (rs = 0.31, p <
0.05, N = 30). Due to the large number of zero scores for interpersonal conflict, these
data were dichotomised into those who reported interpersonal conflict over the
preceding 30 days and those who reported no such conflict and a t-test was carried out.
The mean substance dependence score for the 'conflict' group was 14.2 (S.D. = 8.6;
range = 2-27) and the mean score for the 'no conflict' group was 9.1 (S.D. = 6.7; range =
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0-18). There was no significant difference between the 'conflict' (N = 13) and 'no
conflict' (N = 17) groups in terms of severity of dependence (t (28) = 1.81, p = 0.08,
n.s.), although this finding is approaching significance.
3.4.2 Severity ofTrauma
Nine of the eleven individuals in the 'SUD only' group met at least one of the DSM-IV
criteria for PTSD. It was therefore possible that the PTSD classification did not provide
a clear distinction between the groups. Consequently, further correlational analyses
were conducted to compare the severity of trauma with the outcome measures. These
results are summarised in Table 3.3.
3.4.2.1 Trauma and Health
Pearson's correlations were used to investigate the relationship between severity of
trauma symptomatology and physical or psychological health. There was a significant
positive relationship between level of trauma severity and ratings of physical health
problems (r = 0.42, p < 0.05, N - 30), indicating that individuals with higher levels of
trauma symptomatology reported more physical health problems. A significant positive
association was also found between trauma symptomatology and psychological distress
(r = 0.81, p < 0.01, N - 30), indicating that individuals with higher levels of trauma
symptomatology had greater levels of psychological distress.
3.4.2.2 Trauma and Risk
87
The correlation between severity of trauma and engaging in risk-taking behaviour was
explored using Spearman's rho. There was no significant relationship between levels of
trauma symptomatology and reported risk-taking behaviour (rs = 0.04, p = 0.85, n.s.,N =
30).
The scores on the 'risk' items were once again dichotomised. The trauma mean score
for the group who reported engaging in risk behaviours was 27.9 (S.D. = 12.7; range =
0-44) and the mean score for the group who reported not engaging in risk behaviours
was 25.6 (S.D. = 13.6; range = 3-48). A t-test indicated no significant difference
between those participants in the group who reported being 'at risk' (N = 11) of
acquiring a blood bome vims and those who reported 'no risk' (N = 19) with respect to
levels of trauma symptomatology (t (28) = 0.45, p = 0.66, n.s.).
3.4.2.3 Trauma and Conflict
Spearman's rho indicated that there was no significant relationship between levels of
trauma symptomatology and rates of interpersonal conflict (rs = 0.09,/? = 0.31, n.s., N=
30). A t-test comparing participants who reported experiencing recent 'interpersonal
conflict' (mean = 27.8; S.D. = 11.3; range = 11-48; N = 13) versus those who reported
'no conflict' (mean = 25.5; S.D. = 14.6; range = 0-44; N = 17) also found no significant
difference between these two groups (t (28) = 0.47,/? = 0.65, n.s.).
3.4.3 PTSD Criteria
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To determine whether participants differed in levels of re-experiencing (Criterion B),
avoidance (Criterion C), or arousal (Criterion D), they were divided into two groups
according to whether they met full diagnostic criteria for PTSD (N= 19) or whether they
met no or partial diagnostic criteria (TV = 11). This was to determine whether there were
any significant differences between these groups as it was noted that some individuals
(TV = 9) met at least one of the DSM-IV criterion for PTSD but not full diagnostic
criteria. It was hypothesised that high levels of trauma symptomatology in one of the
three domains could make it difficult to detect differences between the PTSD-SUD and
SUD-only groups. The mean scores and standard deviations for each of these criteria
are summarised in Table 3.6 below.
Table 3.6 Posttraumatic Stress Diagnostic Scale (PDS) means for participants with and
without PTSD
PTSD (TV= 19) Non-PTSD (TV= 11)
PDS Score Mean Std. Deviation Mean Std. Deviation
Re-experiencing 8.9 4.6 6.6 5.2
Avoidance 12.9 4.8 7.0 4.4
Arousal 10.6 3.8 2.7 2.8
Participants in the 'PTSD' group had significantly higher re-experiencing scores than
those in the 'non-PTSD' group (t (28) = 4.03, p = 0.01), significantly higher avoidance




4.1 Summary of findings
The results of this study offer some support for the hypotheses that severity ofPTSD is
positively related to severity of dependence on substances and individuals with PTSD
and SUD are significantly more likely to experience psychological distress and engage
in activities which place them at increased risk of blood borne viruses than those with
SUD alone. A significant positive relationship was found between number of types of
trauma and severity of drug use where individuals who had experienced a greater
number of traumas reported higher levels of dependency on substances. No support was
found for the hypotheses that individuals with comorbid PTSD and SUD would
experience higher rates of interpersonal conflict than those with SUD alone. The results
also indicated that those with PTSD-SUD were more likely to have poorer health than
those with SUD alone but this finding was only approaching significance.
In addition to these a priori findings, exploratory analyses indicated that there was a
significant positive relationship between severity of substance dependence and
psychological distress. Statistically significant associations were found between levels
of substance dependency and interpersonal conflict and between trauma severity and
both physical and psychological health. Comparison of scores on re-experiencing,
avoidance, and arousal symptoms between individuals who met full diagnostic criteria
for PTSD and those who did not indicated that symptom severity scores were
significantly higher for those with diagnosable PTSD. Significant positive correlations
90
were also found the between severity of dependence on substance scores and re-
experiencing, avoidance, and arousal symptom scores.
4.2 Strengths and limitations of the study
A potential strength of the current study is the recruitment from a range of treatment
clinics across a NHS health board area. This allowed greater access to individuals
receiving treatment for opiate dependence and improved generalisability as participants
were not limited to one particular treatment approach or area of residence. The majority
of participants were engaged in a substitute-prescribing programme and a small number
(N—2) were currently in an abstinence-based treatment model. Individuals who were
attending needle exchange services or detoxification were not recruited for ethical
reasons and from the available literature; it seems that findings for these groups of
individuals may have been different to those in maintenance treatment models (Mark et
al., 2006). It was therefore methodologically sounder to use this less heterogeneous
sample. Sampling from a UK population was a particular strength as the links between
the presence of PTSD and other biopsychosocial correlates which have been shown to
influence treatment outcome have not been widely investigated in the literature and only
two studies, which both focused on prevalence rates, have been undertaken using UK
samples (Christo & Morris, 2004; Reynolds et al., 2005). The current study aimed to
increase the generalisability of findings to other UK services by investigating these
associations.
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Whereas other UK studies have focused on prevalence, the current study investigated
links between PTSD and mental health, physical health, blood bome virus risk, and
interpersonal conflict in an injecting drug use sample. These factors were assessed using
standardised measures which were chosen for their sound psychometric properties and
brevity. The measures had subscales which allowed for a range of hypotheses to be
investigated through correlational and comparative analyses and inferences to be drawn
about the impact of comorbid PTSD and SUD on treatment outcomes.
There are also several limitations to this study which may have implications for the
interpretation of the findings. The first is the relatively small sample size of 30
participants. While this sample was determined as being adequate for correlational
analyses by the power calculation, the split between those participants meeting diagnosis
for PTSD and those not meeting the criteria meant that the comparison of these two
groups was likely to be underpowered as the groups did not contain equal numbers.
Therefore, a larger sample, or a sample with a more equal distribution between the two
groups may have yielded significantly different results. This is especially true of the
trend towards significance found for the hypothesis that individuals with PTSD-SUD
would have poorer physical health than those with PTSD alone, as a larger sample may
have allowed detection of a significant difference between the groups. However, it is
worth noting that 97% of all participants reported experiencing an event which they
perceived as "traumatic". Although 73% of the 'non-PTSD' sample did not meet DSM-
IV Criterion A for a traumatic event (mainly due to individuals not reporting that they or
another person was physically injured or there was a perceived threat to life), these
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participants continued to experience a number of symptoms which were consistent with
a stress-response disorder. It may therefore be argued that the PTSD and non-PTSD
groups were, for the most part, not discrete and the results were likely to be affected by
the relatively high levels of post-traumatic stress symptomatology which was evident in
the 'non-PTSD' group. Brewin et al. (1996) has also advised against comparing groups
of individuals with 'subthreshold' or 'lifetime' PTSD with those thought to have current
PTSD as the former groups may have engaged in premature inhibition of emotional
processing.
There is also a possibility that the Posttraumatic Stress Diagnostic Scale (PDS) was not
the most appropriate measure of PTSD to use in the current study as no data is available
on the use of the PDS with other samples of injecting drug users with which to compare
the current sample. However, a comparison of the means and standard deviations for
participants who met full diagnostic criteria for PTSD with the pilot data for the PDS
(Foa et al., 1997) indicated these were very similar and the means and standard
deviations for those who did not meet full criteria for PTSD were slightly higher than
those in the Foa etal. sample for all areas except the 'Arousal' domain.
Difficulties with recruitment are a recognised difficulty with this population, as injecting
drug users can be reluctant to participate in research due to suspicion and lack of trust,
belief that the study was not valuable or that they did not have time to participate
(Barratt etal., 2006; Spooner et al., 1997). These barriers to participation were observed
in the current study as some clients did not believe the research topic was of relevance to
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them and therefore were not inclined to take part. This also has implications for the
relatively high proportion of clients who were found to meet full diagnostic criteria for
PTSD as there may have been a tendency for participants to self-select. It is unclear to
what extent this sample is representative of the injecting drug user population as a
whole, and therefore to what extent the findings of this study are generalisable. This has
been reported as a common difficulty when conducting research with individuals who
are injecting drug users as many studies are unable to generate estimated response rates
(Dodding & Gaughwin, 1997).
Demographic information available from the Scottish Drug Misuse Database (ISD
Scotland, 2008), acquired at the point of individuals entering treatment, reported that the
median age of clients presenting for treatment in Scotland was 30 years and that the ratio
of males to females was two to one. In Lothian, 21% reported injecting heroin in the
month prior to starting treatment and 13% of current injectors reported sharing needles
or syringes in the previous month. Sixty-six per cent of those with substance use
disorders in Lothian were unemployed and 26% reported that their drug use was funded
by crime. Co-occurring physical health issues were present in 65% of new cases of
individuals with substance misuse and mental health was reported as a difficulty in 54%
of cases. There was no measure of the nature or severity of either physical or mental
health problems in the Lothian substance misuse population which makes it difficult to
compare to those in the current study. It appears that the sample in the current study is
somewhat different from the Lothian substance misuse population as a whole in some
respects (i.e. a higher proportion of males and higher rates of unemployment) but may
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still be representative of injecting drug users in Lothian in other respects (i.e. age; rates
of sharing of injecting equipment; criminal activity). It is also important to note that the
Lothian data available represents all individuals with SUD entering treatment in Lothian,
and there may be a subgroup of individuals who are injecting drug users who have a
slightly different demographic however, this information has not been published.
Another potential limitation was the assessment of blood bome virus risk (BBV),
particularly as this was found to be a significant finding in the study. The MAP items
pertaining to risk of BBV transmission address sharing of injecting equipment and
penetrative sex, but not other potential routes of transmission such as sharing other
injecting paraphernalia (such as filters, spoons or tourniquet) or sharing personal
hygiene items such as razors. Thus risk behaviours may have been under detected in the
current sample. In the Marsden etal. (1998) study, 44% (N= 71) of injecting drug users
reported having unprotected sex and 16.5% (N = 15) reported sharing needles and/or
syringes. This indicates higher rates of risk-taking behaviour in Marsden et a/.'s study
compared to the current study which may have been due to the participants being newly
enrolled in substance dependence treatment.
Risk of BBV transmission via other routes could have been investigated by a more
comprehensive measure such as The Blood-bome Virus Transmission Risk Assessment
Questionnaire (BBV-TRAQ), which assesses current injecting risk behaviours, sexual
risk behaviours, and skin penetration risk factors (Fry & Linterzis, 2003). Fifty-seven
per cent of participants in the study did not share injecting equipment but one third did
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report having unprotected penetrative sex. Of those participants who reported having
unprotected sex, 90% had unprotected sex only with a regular partner and therefore may
not have seen any need for condom use. The MAP item relating to injecting behaviour
asks specifically about the sharing of needles and syringes, however, it has been shown
that Hepatitis C seroconversion can be related to the sharing of other injecting
paraphernalia such as filters and spoons (Hagan et al., 2001). Injecting drug users are
more likely to share spoons and filters than syringes and there has also been a link
proposed between the sharing of injecting paraphernalia and sexual intimacy, where the
sharing of injecting paraphernalia is more common amongst regular sexual partners
(Gossop et al., 1997). It has been found that consistent condom use with a main sexual
partner is inversely correlated with sharing of injecting paraphernalia (Kapadia et al.,
2007) and is less common amongst injecting drug users who have a regular sexual
partner (Bogart et al., 2005; Houlding & Davidson, 2003). The lower rate of injecting
risks may also have been due to participants being in maintenance or abstinence-based
treatment and may have been different if recruitment had included those known to
needle exchange services or individuals who were not being supported by any agency.
The stage of treatment which participants had reached may have had an impact on their
severity of drug use and presence of other symptoms such as physical health problems or
BBV risk behaviours. As some of the participants were relatively new to treatment, and
therefore were less likely to be 'stable' on their prescribed opiate substitute (i.e. not
exhibiting any signs of withdrawal), they may have exhibited higher drug use severity
than those who had been in treatment for a longer period of time. Alternatively,
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participants could have been more stable than in the injecting drug use population as a
whole as they were in treatment and therefore potentially have lower levels of severity
of dependence and be less likely to engage in risk-taking behaviours. One way of
overcoming this limitation would be to recruit participants at a specific point in
treatment to aid more direct comparisons, bearing in mind that findings would be more
generalisable to injecting drug users in treatment rather than the IDU population as a
whole. It is also a possibility that those individuals who had higher levels of dependence
were less likely to volunteer to take part in the current study. However, as there is no
published information about levels of dependence in the injecting drug use population
available, it is not possible to determine if this is likely.
Participants in the current study had lower overall dependency means compared to
opiate users in the LDQ pilot study where Raistrick etal. (1994) reported the mean score
to be 20.1 (S.D. = 6.8; range = 5-29). This finding of the current study was also lower
than that reported in Heather et al.'s study of a larger sample where the mean score on
the LDQ for opiate users was 21.3 (S.D. = 6.79; range = 0-30). However, it is worth
noting that a score of 20 is still considered within the 'mild' range of dependency and
comprised 35% of the sample in Heather et al.'s study. Although the current sample had
much lower scores on this measure, the majority still fell within the same severity
bracket as the majority of participants in these other samples. It may therefore have
been useful for other measures of drug use severity, in addition to the dependency score,
to be considered such as presence of polysubstance use, frequency and amount of
consumption of substances, and length of substance using 'career'. While some of this
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information was available, it was not in a format that was directly applicable to
answering the main hypotheses.
4.3 Interpretation of findings
The following section aims to offer explanations for the findings within the context of
the existing literature.
4.3.1 Dependence on Substances and PTSD
The first hypothesis that higher levels of dependence on substances will be associated
with higher levels of PTSD symptomatology was supported by the findings of this study.
The methodology used to test this hypothesis differed from that employed by other
studies - which compared groups of individuals with comorbid PTSD-SUD and SUD
only - as it also investigated the correlation between the continuous variables of trauma
symptomatology scores and substance dependence scores in addition to comparing
groups. However, the positive significant finding is in keeping with some of the other
studies which investigated levels of severity and diagnosis of PTSD (Driessen et al.,
2008; McFall etal., 1992; Reynolds et al., 2005; Stewart et al., 1999). This finding also
appears to overcome one of the limitations of some other studies which chose to
compare groups of individuals with PTSD, 'subthreshold' or 'possible' PTSD, and no
PTSD symptomatology which showed that when split into such groups, the likelihood of
significant differences between each group was reduced (e.g. Bonin et al., 2000; Brown
et al., 1999; Pirard et al., 2005). The failure to find differences between groups may
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reflect the high rates of exposure to traumatic events in this population and the impact of
subthreshold PTSD symptoms on dependence on substances. Therefore investigating
the impact of trauma symptomatology on substance dependence using a correlational
design may be of greater value as some individuals could potentially have exhibited
higher levels of trauma symptomatology in some domains but not others, thus not
fulfilling the DSM-IV criteria for PTSD.
4.3.2 Trauma Exposure and Dependence on Substances
The second hypothesis investigated whether participants who experienced more
traumatic events would exhibit higher levels of substance dependency. A positive
correlation was found between these factors, which is consistent with other studies that
highlight associations between cumulative traumatic experiences, particularly when they
begin in childhood, and increased risk of developing a substance use disorder. The
Adverse Childhood Experiences Study (Edwards et al., 2003; Fellitti et al., 1998)
highlighted the link between cumulative trauma in childhood and subsequent
dependence on substances, although it did not directly link cumulative trauma with
severity of dependence. Bonin et al. (2000) investigated the relationship between
polysubstance use and PTSD and found that individuals who engaged in polysubstance
use and met criteria for PTSD had more extensive trauma histories than those with
PTSD and either alcohol abuse or single illicit drug use. If polysubstance use is taken as
a proxy for severity of dependence on substances, then this finding would support the
finding that increased number of traumas is associated with higher levels of drug
severity.
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4.3.3 Impact ofPTSD-SUD on Physical and Psychological Health
Participants in the current study were allocated to a 'PTSD-SUD' group if they met full
diagnostic criteria for PTSD and a 'SUD only' group if they did not meet full criteria.
Comparison of these groups indicated that the difference in physical health problems
between those with comorbid PTSD and SUD and those with SUD alone was
approaching, but did not reach, significance. This finding does not therefore fully
support previous findings that individuals with PTSD-SUD report significantly more
physical symptoms, such as cardiovascular and neurological symptoms, bodily pain, and
chronic physical health conditions (Ouimette et al., 2006; Tate et al., 2007) but may
have done so if a larger sample size had been available. The physical health of
individuals with SUD is reported to be poorer than the general population in general due
to the negative effects of substance use and associated psychosocial problems (Falck et
al., 2007; McKetin et al., 2008; Williamson et al., 2009). In addition to this, PTSD has
been highlighted as a mediating factor in physical health problems as it has been shown
to be associated with poorer physical health in homeless adults with substance abuse
disorders (Nyamathi et al., 2000; Struening & Padgett, 1990) and trauma-exposed
college students (Flood et al., 2009). This would suggest that the high rates of physical
health problems in individuals with SUD may be so extensive that a ceiling effect is
present such that any additional effects of PTSD may not have a significant observable
effect.
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The current study found that individuals with PTSD-SUD experienced higher levels of
psychological health problems than those with SUD only. This is in keeping with the
findings of the Nyamathi et al. (2000) study which indicated that psychological health
problems were associated with a history of abuse, avoidant coping, low self-esteem and
poor or dysfunctional social support networks in women with substance use disorders.
Comorbid PTSD-SUD has been reported as being associated with a range of other
mental health problems such as depression, anxiety disorders, mania, and psychotic-
spectrum symptomatology (Becker et al., 2005; Bonin et al., 2000; Wasserman et al.,
1997). There is also a proposed link between PTSD-SUD and Cluster B personality
disorders (Brown et al., 1999; Casillas & Clark, 2002; Palacios et al., 1999).
4.3.4 Impact of PTSD-SUD on Risk-Taking Behaviour
Participants with comorbid PTSD-SUD were significantly more likely to engage in
behaviours which placed them at increased risk of contracting a blood borne virus
(BBV) such as sharing needles and syringes and engaging in unprotected penetrative
sex. This supports previous studies which showed that risk-taking behaviour was
associated with the development of PTSD and substance use disorders (Kingston &
Raghavan, 2009; Reed et al., 2007). It has been proposed that PTSD is a mediating
factor in the development of BBV risk behaviours in women who are injecting drug
users and have a history of childhood sexual abuse (Plotzker et al., 2007; Roxburgh et
al., 2006), however, the association is less clear cut for men where substance misuse
appears to be a risk factor for BBV but childhood sexual abuse is not (van Dorn et al.,
2005). Combat veterans with comorbid PTSD and SUD had significantly higher rates of
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HTV infection than those with either PTSD or SUD, indicating that they are likely to
have engaged in BBV risk behaviours following the development of PTSD and SUD
(Hoff et al., 1997). It may therefore be the case that individuals with comorbid PTSD-
SUD are at greater risk ofengaging in risk behaviours.
4.3.5 Impact ofPTSD-SUD on Interpersonal Conflict
Rates of interpersonal conflict were not found to be associated with a diagnosis of PTSD
in injecting drug users in the current study. There are several reasons that may explain
why the PTSD-SUD group did not exhibit higher levels of interpersonal conflict than the
SUD only group. Firstly, just over half of the sample did not have a partner and many
reported having limited contact with family and friends, therefore the potential to
experience interpersonal conflict was limited for many of the participants. It is possible
that difficulties with interpersonal relationships are so severe for some of these
individuals that they are simply no longer involved in any interpersonal relationships.
The measure of interpersonal conflict may not have detected such pronounced
difficulties as it relies upon the presence of interpersonal relationships. A measure which
took into account the presence and quality of interpersonal relationships may have been
more appropriate.
Additionally, the wording of the MAP item relating to interpersonal conflict ("had major
arguments") may have led participants to report any incident of discordance between
themselves and others, irrespective of the severity of the conflict. The MAP pilot study
indicated that 20.7% of drug users reported having conflict with their partner, 10.7% had
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conflict with relatives, and 5.4% had conflict with friends (Marsden et al., 1998). This
indicates that the current sample had similar levels of conflict with partners but higher
levels of conflict with relatives and friends. As there was no way of determining the
nature of the interpersonal conflict, it is still possible that individuals with PTSD-SUD
experienced more severe conflict but not more frequent conflict than those with SUD
only. The investigation of the link between interpersonal conflict, PTSD, and SUD
could have been explored using a more detailed measure such as the Conflict Tactics
Scale-Revised (CTS2; Straus et al., 1996) which has been utilised in studies of domestic
violence in couples with PTSD and substance dependence (e.g. Najavitis et al., 2004;
Parrott et al., 2003). This would indicate the nature and severity of episodes of
interpersonal conflict and also whether the conflict was perpetrated by the participant or
their partner. However, it could not address interpersonal conflict with relatives or
friends or the issue of individuals who do not have any relationships as a result of severe
interpersonal difficulties. It may therefore be necessary to use a combination of
measures to clarify any differences in the severity and frequency of interpersonal
conflict.
It is possible that the link between interpersonal conflict and PTSD-SUD may be
mediated by gender, however the low numbers of female participants in the current
study (N= 6) prevented this from being investigated. Hedtke et al. (2008) reported that
women with PTSD-SUD who experienced an episode of interpersonal violence in the
period between baseline measures and one- and two-year follow up were more
significantly more likely to exhibit PTSD-SUD than those who did not. Similarly,
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Ullman, Filipas et al. (2006) discovered that women who experienced negative social
reactions to their sexual assault and had less social support were more likely to exhibit
comorbid PTSD and substance abuse. However, Benda (2006) found that social support
(from family, friends or others) had a significant effect on substance use disorder
treatment outcome and PTSD severity for women but not for men.
4.3.6 Relationship between Substance Dependence and Psychological Health
Exploratory analyses indicated a significant correlation between severity of substance
dependence and psychological problems. The link between substance use disorders and
mental health problems has been documented in a number of studies (e.g. Cleary et al.,
2009; Darke & Ross, 1997) and this finding is therefore not surprising. It is possible
that this finding is due in part to the development of substance dependence as a method
of coping with mental health problems. Alternatively, the neurological impact of
substances may lead some individuals to develop psychological symptoms. There is also
a possibility that psychological symptoms exhibited by individuals with severe
substance dependence are due to withdrawal and/or intoxication.
4.3.7 Relationship between Trauma and Health
In addition to the comparison of the PTSD-SUD and SUD only groups discussed above,
exploratory analysis highlighted a significant positive correlation between levels of
trauma symptomatology and symptoms of both physical and psychological health
problems. Such findings have been found in various groups such as older adults (Petkus
et al., 2009), women (Dennis et al., 2009; Lang et al., 2008; Wiesbecker & Clark, 2007),
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and children (Dorn et al., 2008). This finding therefore supports previous studies which
have shown that trauma symptomatology is a risk factor for poorer physical and
psychological health. In the instance of physical health problems this may be due to
direct physiological effects of injury sustained during the traumatic event or as a
consequence of subsequent behaviours such as poor self-care, adverse effects of
maladaptive coping practices such as substance abuse or self injury. The increase in
psychological health problems may reflect the symptom overlap between trauma and
other Axis I disorders, such as hyperarousal, or the development of Axis I disorders
following exposure to traumatic events such as major depressive disorder or generalised
anxiety.
4.3.8 Comparison ofPTSD-SUD and SUD-Only group on PTSD Criteria
The PTSD-SUD group had significantly higher scores than the SUD only group for all
three groups of PTSD symptoms (re-experiencing, avoidance, and arousal). This finding
indicates that the two groups differed significantly in the severity of PTSD symptoms
experienced. Therefore the lack of significant differences between the groups on
factors such as physical health and interpersonal conflict may not be due to the presence
of trauma symptoms in the SUD only group (which could reduce the likelihood of
detecting a significant difference between the groups), but may indicate that these
factors are not influenced by the presence ofPTSD.
4.3.9 Relationship between Dependence and PTSD Criteria
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A significant positive relationship was found between severity of dependence and all
three groups of PTSD symptoms. This suggests that individuals with SUD are not more
likely to experience arousal symptoms than re-experiencing or avoidance symptoms as
has been reported elsewhere (Ford et al., 2007; Rash et al., 2008; Saladin et al., 1995).
It has been argued that observed higher rates of 'arousal' (Criterion D) symptoms in
individuals with SUD may be due to symptoms of dependence and withdrawal
'mimicking' trauma symptoms. However, the findings of the current study do not
support this as severity of dependence was also associated with higher levels of re-
experiencing and avoidance symptoms.
4.4 Theoretical implications
This section aims to link the findings of the current study to some of the hypotheses
which have been proposed to explain the association between PTSD and SUDs.
4.4.1 Self-medication Hypothesis
The self-medication hypothesis proposes that substance use disorders occur when
individuals who have experienced a traumatic event use substances as a method of
coping with ('self-medicating') PTSD symptomatology. One method of establishing a
relationship between PTSD and SUD is to examine whether the symptoms of one
disorder increase as the symptoms of the other increase, thus indicating a gradient of
effect (Stewart & Conrod, 2003). This feature of the relationship between PTSD-SUD
appears to be supported by the finding of the current study that as levels of trauma
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symptomatology increases, so does the severity of dependence on substances. This may
be due to increases in arousal symptoms caused by substance use leading to the
increased use of substances in an attempt to maintain self-medication. An explanation
which has been proposed to account for this relationship is that withdrawal from
substances may result in similar symptoms to PTSD arousal symptoms and therefore
will lead to individuals with PTSD reporting higher levels of both symptoms (Saladin el
al., 1995). This explanation is not supported by the findings of the current study, which
showed that severity of dependence was associated with higher levels of re-experiencing
and avoidance symptoms, not just arousal symptoms. Furthermore, the items used to
determine SUD severity were based on features of dependency other than just those of
withdrawal. It is possible that the use of substances to avoid symptoms of PTSD may
prevent individuals from being able to 'process' the traumatic event and therefore act to
maintain the symptoms, hence self-medication becomes a self-perpetuating cycle.
4,4.2 High Risk Hypothesis
The high risk hypothesis proposes that individuals who have a SUD are more likely to
engage in high risk behaviours, which place them at increased risk of experiencing a
traumatic event. This in turn may lead to the development of PTSD. The temporal
relationship between the onset of PTSD and SUD has been investigated to determine if
SUD follows or precedes the development ofPTSD symptoms (e.g. Cottier et al., 2001;
Johnson et al., 2006). This question was not addressed in the current study as, although
time of first heroin use was recorded, it is impossible to determine from this information
when dependence became established and whether this preceded the development of
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PTSD symptoms. Furthermore, the majority of individuals in the study experienced
multiple traumas and only the timing of the most distressing trauma was recorded.
Therefore it was not possible to determine temporal links between the onset of PTSD
and SUD. The evidence provided in the literature is inconsistent and it is not clear
whether there is a temporal causal link between PTSD and SUD (e.g. Cottier et al.,
2001; Johnson et al., 2006; Stewart et al., 1998). However, the finding in the current
study that all participants except one experienced a traumatic event and all had been
diagnosed with substance dependence suggests that there may be other mediating factors
which lead to the development of PTSD. This factor may be due to the development of
other psychological symptoms and potentially other Axis I disorders. This would fit
with the findings of the current study where individuals with PTSD-SUD were found to
have significantly higher symptoms of psychological health problems.
4.4.3 Vulnerability Hypothesis
The vulnerability hypothesis or 'susceptibility hypothesis' states that individuals who
misuse substances may be more likely to develop PTSD than those who do not have
substance misuse problems. This may be due to an underlying factor such as difficulties
associated with Axis II disorders (i.e. emotion dysregulation, maladaptive thinking
patterns, interpersonal difficulties, impulse control), cognitive impairment, or poor
coping strategies. This has been linked to the situation-specific use of substances by
some individuals to manage their PTSD symptoms. Situations which have been shown
to be associated with greater substance use are those where unpleasant emotions,
physical discomfort, and conflict with others have been experienced (Sharkansky et al.,
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1999). This finding is partially supported by the current study as individuals with
greater levels of dependency were found to have higher levels of psychological distress
but not more physical symptoms or episodes of interpersonal conflict. Increased levels
of substance dependence were also associated with higher levels of trauma
symptomatology. Therefore individuals with PTSD-SUD may have an underlying
vulnerability which results in features associated with psychological distress (or
difficulties with emotion regulation) and interpersonal functioning. It is unclear whether
a significant difference in conflict rates between those with PTSD-SUD and those with
SUD alone was not found because individuals with PTSD were in less contact with
family and friends or whether they did experience higher rates of conflict but with
groups of people who were not included in the MAP questionnaire such as
'acquaintances' (e.g. peers on treatment programme or individuals from the local drug
scene) and others who were not family or friends (e.g. staff from voluntary or statutory
agencies). It is also possible that individuals who experience higher rates of
interpersonal conflict and have poorer coping strategies may not seek or engage in
treatment for injecting drug use and so were not recruited to this study. Alternatively,
these individuals may be enrolled in treatment programmes but these difficulties lead




The high prevalence rates of PTSD amongst injecting dmg users reported in other
studies and replicated in the current study suggest that screening for PTSD at the point
of entry to substance misuse treatment would be beneficial. Evans & Sullivan (1995)
recommend routine enquiry about exposure to traumatic events. It is recommended that
this assessment be carried out when individuals are abstinent and have completed the
withdrawal process (Read et al., 2003). Brief screening tools such as the PTSD
Checklist Civilian Version (PCL-C; Weathers et al., 1994) or the Penn Inventory
(Hammarberg, 1992) have been investigated for use with individuals with SUD and
revised cut-offs for substance misusing populations are available (Harrington &
Newman, 2007). These tools could thus be used by healthcare providers such as GPs or
drugs workers and would allow them to refer individuals with suspected PTSD-SUD to
psychological or psychiatric services for further assessment and intervention if required.
4.5.2 Intervention
4.5.2.1 Clinical Guidelines
If comorbid PTSD and SUD are mutually maintaining disorders, then integrated
treatment should lead to better outcomes for both conditions than treating either disorder
alone or sequentially. However, the National Institute of Clinical Excellence Guidelines
(NICE, 2005) recommend that individuals with PTSD with dmg or alcohol dependence
should be treated for their dmg or alcohol problem prior to treatment for PTSD. This
recommendation is based on a 'Grade C' rating which is given where there is a dearth of
empirical evidence and is based on the assumption that to attempt to treat PTSD without
first resolving substance misuse will lead to an increased likelihood of destabilisation or
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relapse. This has not been borne out in studies which aim to treat comorbid PTSD-SUD
with a trauma-informed approach as no adverse effects on substance abuse or psychiatric
symptoms have been observed (Cohen & Hien, 2006; Killeen et al., 2008).
In contrast to UK NICE guidelines, US guidelines recommend the use of an integrated
treatment for PTSD and Substance Use Disorder (ISTSS, 2009). Their guidelines
endorse the use of 'Seeking Safety' (Najavits, 2002), which is the only treatment
approach with established effectiveness based on randomized, well-controlled trials.
Thus whilst initial methods of treating comorbid PTSD-SUD utilised a sequential
approach in which SUD had to be addressed prior to commencing treatment for PTSD, a
growing body of research evidence indicates that integrated treatment is more beneficial
for this population (Najavits et al., 2009).
4.5.2.1 Integrated treatment
The pilot study evaluating the 'Seeking Safety' integrated programme for PTSD and
substance dependence found significant improvements in substance use, trauma-related
symptoms, suicide risk, suicidal thoughts, social adjustment, family functioning,
problem solving, and depression (Najavits et al., 1998). Further studies which have
compared 'Seeking Safety' with treatment-as-usual have also shown significant
improvements in substance use, PTSD symptoms, and psychiatric symptoms in a range
of populations including women, homeless female veterans, adolescents, and dually
diagnosed men (Desai et al., 2008; Hien et al., 2004; Najavits et al., 2005; Najavits et
al., 2006). The results of these studies suggest that the implementation of trauma-
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informed interventions for comorbid PTSD-SUD, either in individual or group format,
would be ofvalue to service users such as those who participated in the current study.
4.5.3 Links to Policy Documents
The findings of the current study also have implications for service delivery with
reference to national policies and targets. For example, the 18 Week Referral to
Treatment (RTT) pathway was set as a benchmark for service delivery in the NHS
Improvement Plan (DoH, 2004). It would be anticipated that by providing a
comprehensive integrated treatment for comorbid PTSD and substance misuse, both
substance misuse and trauma services would be more effectively able to meet this target
as a single integrated treatment would be more easily implanted in an eighteen-week
time-frame than sequential treatments, which could potentially involve treatment being
offered by more than one service.
Similarly, the third Health Improvement, Efficiency, Access and Treatment (HEAT)
target set by the Scottish Government in 2007 is of particular relevance to individuals
with substance use disorders. The target aims to reduce psychiatric hospital
readmissions and as it was noted in that substance misuse is the main diagnosis in 14%
of psychiatric hospital readmissions, this is an area which has been highlighted as
requiring further development. It is recognized that there are strong associations
between substance misuse and trauma and the Scottish Government has recommended
that substance misuse services should develop and implement appropriate psychological
treatments to meet the mental health needs of their client group. Given that an
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association between comorbid PTSD and substance misuse, and overutilization of
overnight psychiatric inpatient services has been reported (Brown et al., 1999) a move
towards integrated treatment for these clients would be of value and in keeping with
aims to meet this target.
Finally, the Scottish Government set out its vision for drug treatment services in the
document 'The Road to Recovery' (2008). This document emphasizes a recovery
approach which is defined as "a process through which an individual is enabled to move
on from their problem drug use, towards a drug-free life" (p.23). As lower levels of
abstinence and higher rates of relapse have been observed in samples of clients with
comorbid PTSD and substance misuse (Brady, 2001), it seems vital that both conditions
be treated if abstinence and recovery are to be achieved. This document also tasks
substance misuse services with offering a range of appropriate treatment services and
effective integration with generic services. Clearly the development of links between
substance misuse and trauma services, or the training of staff in substance misuse
services to enable them to work with comorbid service users, would fulfill these
requirements.
In keeping with these policies and arising in part from the information gathered in this
study, the local substance misuse directorate psychology service has implemented
training for psychologists working with clients who present with comorbid PTSD-SUD.
It is in the process of setting up an integrated treatment group for PTSD-SUD
participants, using the 'Seeking Safety' protocol, which will be co-facilitated by a
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psychologist from the substance misuse psychology service and a therapist from the
specialist trauma service. It is hoped that the outcome data from this group will enable
an evaluation of the effectiveness of an integrated treatment approach for PTSD in
injecting drug users in a community setting.
4.6 Future research directions
While it is now widely accepted that high prevalence levels ofPTSD exist in samples of
individuals with substance use disorders, the implications for treatment of these
individuals is less well researched. The current study indicates that comorbid PTSD-
SUD is associated with poorer psychological health and increased risk of engaging in
activities which may result in blood borne vims infection. Despite the limitations of the
study, these findings suggest that individuals entering substance misuse services may
benefit from assessment and intervention which addresses these factors by assessing for
PTSD-SUD comorbidity and offering integrated treatment if required. Further research
into the effectiveness of these developments in service delivery would be a valuable
contribution to the existing literature.
Another potential area of research includes the role of Complex PTSD (CPTSD) in the
presentation of individuals with substance use disorders (SUDs). Given the number of
participants in the current study who experienced multiple traumas or prolonged trauma
such as childhood abuse, domestic abuse, or imprisonment, it would be of value to
determine if these individuals have a different presentation and/or prognosis than those
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with PTSD arising from a single, discrete traumatic event. The current study highlights
the complexity of functional relations between PTSD and SUD. These pathways are
still not well understood and future research investigating the links between these
disorders and associated disorders would be of value. This could include the use of
longitudinal studies looking at the development of PTSD and substance use disorders or
differences in presentation between those with single and those with multiple or repeated
experiences of trauma.
In conclusion, the current study found that PTSD is associated with higher rates of
dependence, psychological distress, and risk of acquiring a blood bome virus in a
community sample of injecting drug users. These findings highlight that injecting drug
users with comorbid trauma symptomatology have additional areas of difficulty as
compared to those who do not. It is therefore important to assess for comorbid PTSD
and other psychological problems when individuals enter treatment for substance
misuse, and to offer integrated treatment models for PTSD-SUD if required. This in
turn should lead to more effective outcomes and provide the highest quality of care for
injecting drug users with comorbid or multiple psychological disorders.
115
REFERENCES
American Psychiatric Association (1994). Diagnostic and Statistical Manual ofMental
Disorders, Fourth Edition. Washington, DC: American Psychiatric Press.
American Psychiatric Association (1987). Diagnostic and Statistical Manual ofMental
Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Press.
Barratt, M.J., Norman, J.S., & Fry, C.L. (2006). Positive and negative aspects of
participation in illicit drug research: Implications for recruitment and ethical conduct.
International Journal ofDrug Policy, 18, 235-238.
Beck, A.T., Ward, C.H., Mendelson, M., Mock, M.D., & Erbaugh, J. (1961). An
Inventory for Measuring Depression. Archives ofGeneral Psychiatry, 4, 561-571.
Becker, M.A., Noether, CD., Larson, M.J., Gatz, M., Brown, V., Heckman, J.P., &
Giard, J. (2005). Characteristics ofWomen Engaged in Treatment for Trauma and Co-
Occuring Disorders: Findings From a National Multisite Study. Journal ofCommunity
Psychology, 33, 429-443.
Benda, B.B. (2006). Survival Analyses of Social Support and Trauma Among
Homeless Male and Female Veterans Who Abuse Substances. American Journal of
Orthopsychiatry, 76, 70-79.
Blake, D.D., Weathers, F.W., Nagy, L.M., Kaloupek, D.G., Klauminzer, G., Chamey, C.
S., & Keane, T.M. (1990). A clinician rating scale for assessing current and lifetime
PTSD: The CAPS. Behavior Therapist, 13, 187-188.
116
Blanchard, E.B., Hickling, E.J., Taylor, A.E., Loos, W.R., & Gerardi, R. J. (1994).
Psychological morbidity associated with motor vehicle accidents. Behavior Research
and Therapy, 32, 283-290.
Bogart, L.M., Krai, A.H., Scott, A., Anderson, R., Flynn, N., Gilbert, M., & Bluthenthal,
R.N. (2005). Condom Attitudes and Behaviors Among injection Drug Users
Participating in California Syringe Exchange Programs. AIDS and Behavior, 9, 423-
432.
Bonin, M.F., Norton, G.R., Asmundson, G.J.G., Dicurzio, S., & Pidlubney, S. (2000).
Drinking away the hurt: the nature and prevalence of PTSD in substance abuse patients
attending a community-based treatment program. Journal of Behavior Therapy and
Experimental Psychiatry, 31, 55-66.
Brady, K.T. (2001). Comorbid Posttraumatic Stress Disorder and Substance Use
Disorders. Psychiatric Annals, 37,313-319.
Brewin, C.R., Dalgleish, T., & Joseph, S. (1996). A Dual Representation Theory of
Posttraumatic Stress Disorder. PsychologicalReview, 103, 670-686.
Brewin, C.R., & Holmes, E.A. (2003). Psychological theories of posttraumatic stress
disorder. ClinicalPsychology Review, 23, 339-376.
Brown, P.J., Stout, R.L., & Mueller, T. (1999). Substance Use Disorder and
Posttraumatic Stress Disorder Comorbidity: Addiction and Psychiatric Treatment Rates.
Psychology ofAddictive Behaviors, 13, 115-122.
Cacciola, J.S., Koppenhaver, J.M., McKay, J.R., & Alterman, A.I. (1999). Test-Restest
Reliability of the Lifetime Items on the Addiction Severity Index. Psychological
Assessment, 11, 86-93.
117
Casillas, A. & Clark, L.A. (2002). Dependency, impulsivity, and self-harm: Traits
hypothesized to underlie the association between cluster B personality an substance use
disorders. Journal ofPersonality Disorders, 16, 424-436.
Christo, G. & Morris, C. (2004). Substance-misusers' Anxiety and Traumatic Event
Prevalence. Drugs: education, prevention andpolicy, 11, 35-47.
Christo, G., Spurred, S., & Alcorn, R. (2000). Validation of the Christo Inventory for
Substance-misuse Services (CISS): a simple outcome evaluation tool. Drug andAlcohol
Dependence, 59, 189-197.
Clark, H.W., Masson, C.L., Delucchi, K.L., Hall, S.M., & Sees, K.L. (2001). Violent
traumatic events and drug abuse severity. Journal ofSubstance Abuse Treatment, 20,
121-127.
Cleary, M., Hunt, G.E., Matheson, S., & Walter, G. (2009). Psychosocial treatments for
people with co-occuring severe mental illness and substance misuse: systematic review.
Journal ofAdvancedNursing, 65, 238-258.
Cocozza, J.J., Jackson, E.W., Hennigan, K., Morrissey, J.P., Reed, B.G., Fallot, R., &
Banks, S. (2005). Outcomes for women with co-occuring disorders and trauma:
Program-level effects. Journal ofSubstance Abuse Treatment, 28, 109-119.
Coffey, S.F., Dansky, B.S., Falsetti, S.A., Saladin, M.E., & Brady, K.T. (1998).
Screening for PTSD in a Substance Abuse Sample: Psychometric Properties of a
Modified Version of the PTSD Symptom Scale Self-Report. Journal of Traumatic
Stress, 77, 393-399.
118
Cohen, L.R. & Hien, D.A. (2006). Treatment Outcomes for Women With Substance
Abuse and PTSD Who Have Experienced Complex Trauma. Psychiatric Services, 57,
100-106.
Cottier, L.B., Nishith, P. & Compton, W.M. 3rd. (2001). Gender Differences in Risk
Factors for Trauma Exposure and Post-traumatic Stress Disorder Among Inner-City
Drug Abusers In and Out of Treatment. Comprehensive Psychiatry, 42, 111-117.
Creamer, M., Bell, R., & Salvina, F. (2003). Psychometric properties of the Impact of
Event Scale-Revised. Behaviour Research and Therapy, 41, 1489-1496.
Currie, S.R., el-Guebaly, N., Coulson, R., Hodgins, D., & Mansley, C. (2004). Factor
Validation of the Addiction Severity Index Scale Structure in Persons With Concurrent
Disorders. PsychologicalAssessment, 16, 326-329.
Darke, S., Hall, W., Wodak, A., Heather, N., & Ward, J. (1992). Development and
validation of a multi-dimensional instrument for assessing outcome of treatment among
opiate users: the Opiate Treatment Index. British Journal ofAddiction, 87, 733-742.
Darke, S., Swift, W., & Hall, W. (1994). Prevalence, severity and correlates of
psychological morbidity among methadone maintenance clients. Addiction, 89, 211-
217.
Darke, S. & Ross, J. (1997). Polydrug dependence and psychiatric comorbidity among
heroin injectors. Drug andAlcohol Dependence, 48, 135-141.
Darke, S., Ward, J., Hall, W., Heather, N., & Wodak, A. (1991). The Opiate Treatment
Index (OTI) Researcher's Manual. National Drug and Alcohol Research Centre
TechnicalReport Number 11. Sydney: National Drug and Alcohol Research Centre.
119
Davidson K.M. (2007). Cognitive therapy for personality disorders: a guide for
clinicians. Second Edition. Routledge: Hove.
Day, E. & Crome, IB. (2002). Physical Health Problems. In T. Petersen & A.
McBride (Eds.). Working with Substance Misuse: A Guide to Theory and Practice.
London: Routledge.
Dennis, M.F., Flood, A.M.,Reynolds, V., Araujo, G., Clancy, C P., & Barefoot, J.C.
(2009). Evaluation of lifetime trauma exposure and physical health in women with
posttraumatic stress disorder or major depressive disorder. Violence Against Women,
15,618-627.
Department ofHealth (2004). The NHS Improvement Plan: Putting People at the Heart
ofPublic Services. London: The Stationary Office.
Desai, R.A., Harpaz-Rotem, I., Najavits, L.M. & Rosenheck, R.A. (2008). Impact of
the Seeking Safety Program on Clinical Outcomes Among Homeless Female Veterans
With Psychiatric Disorders. Psychiatric Services, 59, 996-1003.
Dodding, J. & Gaughwin, M. (1997). A new recruiting strategy to allow estimates of
response rates in studies with people who inject drugs. Drug and Alcohol Dependence,
47, 155-157.
Dorn, T., Yzermans, J.C., Spreeuwenberg, P.M.M., Schilder, A., & van der Zee, J.
(2008). A cohort study of the long-term impact of a fire disaster on the physical and
mental health of adolescents. Journal ofTraumatic Stress, 21, 239-242.
Driessen, M., Schulte, S., Luedecke, C., Schaefer, I., Sutmann, F., Ohlmeier, M. et al.
(2008). Trauma and PTSD in Patients With Alcohol, Drug, or Dual Dependence: A
Multi-Center Study. Alcoholism: Clinical andExperimentalResearch, 32, 481-488.
120
Edwards, V.J., Holden, G.W., Felitti, V.J., & Anda, R.F. (2003). Relationship Between
Multiple Forms of Childhood Maltreatment and Adult Mental Health in Community
Respondents: Results From the Adverse Childhood Experiences Study. American
Journal ofPsychiatry, 160, 1453-1460.
Effective Interventions Unit (2003). Integrated Care for Drug Users Assessment:
Digest of Tools Used in the Assessment Process and Core Data Sets. Edinburgh:
Scottish Executive.
Ehlers, A., & Clarke, D.M. (2000). A cognitive model of posttraumatic stress disorder.
Behaviour Research and Therapy, 38, 319-345.
Evans, K.E. & Sullivan, J.M. (1995). Treating Addicted Survivors of Trauma. London:
Guilford Press.
Falck, R.S., Wang, J., & Carlson, R.G. (2007). Health status of illicit stimulant drug
users in rural Ohio. Journal ofPsychoactive Drugs, Suppl 4, 401-405.
Falsetti, S.A., Resnick, H.S., Resnick, P.A., & Kilpatrick, D. (1993). The Modified
PTSD Symptom Scale: A brief self-report measure of posttraumatic stress disorder.
Behavior Therapist, 16, 161-162.
Farley, M., Golding, J.M., Young, G., Mulligan, M., & Minkoff, J.R. (2004). Trauma
history and relapse probability among patients seeking substance abuse treatment.
Journal ofSubstance Abuse Treatment, 27, 161-167.
Felitti, V.J., Anda, R.F., Nordenberg, D., Williamson, D.F., Spitz, A.M., Edwards, V.,
Koss, M.P., & Marks, J.S. (1998). Relationship of Childhood Abuse and Household
121
Dysfunction to Many of the Leading Causes of Death in Adults. American Journal of
PreventativeMedicine, 14, 245-258.
Fisher, J. (2000). Addictions and Trauma Recovery. Retrieved 2 June 2009 from
http://www.janinafisher.com/pdfs/addictions.pdf.
Flood, A.M., McDevitt-Murphy, M.E., Weathers, F.W., Eakin, D.E., & Benson, T.A.
(2009). Substance use behaviors as a mediator between posttraumatic stress disorder and
physical health in trauma-exposed college students. Journal ofBehavioral Medicine, 32,
234-243.
Foa, E.B. (1995). Posttraumatic Stress Diagnostic Scale Manual. San Antonio, TX:
Pearson Assessment.
Foa, E.B., & Cahill, S.P. (2001). Emotional processing in psychological therapies. In
N.J. Smelser & P.B. Bates (Eds ), International encyclopedia of the social and
behavioural science. New York: Elsevier.
Foa, E.B., Cashman, L., Jaycox, L., & Perry, K. (1997). The Validation of a Self-
Report Measure of Posttraumatic Stress Disorder: The Posttraumatic Diagnostic Scale.
PsychologicalAssessment, 9, 445-451.
Foa, E.B., Riggs, D.S., Dancu, C.V., & Rothbaum, B.O. (1993). Reliability and
Validity of a Brief Instrument for Assessing Post-Traumatic Stress Disorder. Journal of
Traumatic Stress, 6, 459-473.
Foa, E.B., & Rothbaum, B.O. (1998). Treating the trauma ofrape. Cognitive-behavior
therapyfor PTSD. New York: Guilford Press.
122
Foa, E.B., Steketee, G., & Rothbaum, B.O. (1989). Behavioral/cognitive
conceptualisation ofpost-traumatic stress disorder. Behavior Therapy, 20, 155-176.
Foa, E.B. & Tolin, D.F. (2000). Comparison of the PTSD Symptom Scale-Interview
Version and the Clinician-Administered PTSD Scale. Journal of Traumatic Stress, 13,
181-191.
Follette, V.M., Polusny, M.A., Bechtle, A.E., & Naugle, A.E. (1996). Cumulative
Trauma: The Impact of Child Sexual Abuse, Adult Sexual Assault, and Spouse Abuse.
Journal ofTraumatic Stress, 9, 25-35.
Ford, J.D. (1999). PTSD and disorders of extreme stress following warzone military
trauma: Comorbid but distinct syndromes? Journal of Consulting and Clinical
Psychology, 67, 3-12.
Ford, J.D., Hawke, J., Alessi, S., Ledgerwood, D., & Petry, N. (2007). Psychological
trauma and PTSD symptoms as predictors of substance dependence treatment outcomes.
Behaviour Research and Therapy, 45, 2417-2431.
Ford, P. (2003). An evaluation of the Dartmouth Assessment ofLifestyle Inventory and
the Leeds Dependence Questionnaire for use among detained psychiatric inpatients.
Addiction, 98, 111-118.
Fry, C.L., & Lintzeris, N. (2003). Psychometric properties of the Blood-borne Virus
Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction, 98, 171-178.
Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995).
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in
English and Australian samples of heroin, cocaine and amphetamine users. Addiction,
90, 607-614.
123
Gossop, M., Griffiths, P., Powis, B., Williamson, S., Fountain, J., & Strange, J. (1997).
Continuing drug risk behaviour: Shared use of injecting paraphernalia among London
heroin injectors. AIDS Care, 9, 651-660.
Grubaugh, A.L., Magruder, K M., Waldrop, A.E., Elhai, J.D., Knapp, R.G., & Frueh, C.
(2005). Subthreshold PTSD in Primary Care: Prevalence, Psychiatric Disorders,
Healthcare Use, and Functional Status. The Journal ofNervous and Mental Disease,
193, 658-664.
Hagan, H., Thiede, H., Weiss, N.S., Hopkins, S.G., Duchin, J.S., & Alexander, E. R.
(2001). Sharing of drug preparation equipment as a risk factor for hepatitis C.
American Journal ofPublic Health, 91, 42-46.
Hammarberg, M. (1992). Penn Inventory for posttraumatic stress disorder:
Psychometric properties. Psychological Assessment, 4, 204-216.
Harrington, T. 8c Newman, E. (2007). The psychometric utility of two self-report
measures among women substance users. Addictive Behaviors, 32, 2788-2798.
Heather, N., Raistrick, D., Tober, G., Godfrey, C., & Parrott, S. (2001). Leeds
Dependence Questionnaire: New Date from a Large Sample of Clinic Attenders.
Addiction Research & Theory, 9, 253-269.
Hedke, K.A., Ruggiero, K.J., Fitzgerald, M.M., Zinzow, H.M., Saunders, B.E., Resnick,
H.S., & Kilpatrick, D.G. (2008). A Longitudinal Investigation of Interpersonal
Violence in Relation to Mental Health and Substance Use. Journal ofConsulting and
Clinical Psychology, 76,633-647.
124
Herman, J.L. (1992). Complex PTSD: A Syndrome in Survivors of Prolonged and
Repeated Trauma. Journal ofTraumatic Stress, 5, 377-391.
Hien, D., Cohen, L., & Campbell, A. (2005). Is traumatic stress a vulnerability factor
for women with substance use disorders? Clinical Psychology Review, 25, 813-823.
Hien, D A, Cohen, L.R., Mierel, G.M., Litt, L.C. & Capstick, C. (2004). Promising
Treatments for Women with Comorbid PTSD and Substance Use Disorders. American
Journal ofPsychiatry, 161, 1426-1432.
Hien, D.A., Nunes, E., Levin, F.R., & Fraser, D. (2000). Posttraumatic stress disorder
and short-term outcome in early methadone treatment. Journal of Substance Abuse
Treatment, 19, 31-37.
Hiller, W., Zaudig, M., & Mombour, W. (1995). ICDL Internationale Diagnosen
Checkliste fur ICD-10. Bern: Huber.
Hoff, R.A., Beam-Goulet, J., & Rosenheck, R.A. (1997). Mental disorder as a risk
factor for human immunodeficiency virus infection in a sample of veterans. Journal of
Nervous andMentalDisease, 185, 556-560.
Houlding, C. & Davidson, R. (2003). Beliefs as predictors of condom use by injecting
drug users in treatment. Health Education Research, 18, 145-155.
ISD Scotland (2008). DrugMisuse Statistics Scotland. Edinburgh: ISD Publications.
International Society for Traumatic Stress Studies (2009). PTSD Treatment Guidelines.
In E. Foa, T.M. Keane, M.J. Friedman & J.A. Cohen (Eds.). Effective Treatments for
PTSD: SecondEdition. New York: Guilford Press.
125
Jaycox, L.H., Zoellner, L., & Foa, E.B. (2002). Cognitive-Behavior Therapy for PTSD
in Rape Survivors. Journal ofClinical Psychology, 58, 891-906.
Johnson, S.D. (2008). Substance use, post-traumatic stress disorder and violence.
Current Opinion in Psychiatry, 21, 242-246.
Johnson, S.D., Striley, C., & Cottier, L.B. (2006). The association of substance use
disorders with trauma exposure and PTSD among African American drug users.
Addictive Behaviors, 31, 2063-2073.
Kapadia, F., Latka, M.H., Hudson, S.M., Golub, E.T., Campbell, J.V., Bailey, S., Frye,
V., & Garfein, R.S. (2007). Correlates of consistent condom use with main partners by
partnership patterns among young adult male injection drug users from five US cities.
Drug andAlcohol Dependence, 91(Suppl 1), S56-S63.
Kessler, R.C., Ruscio, A.M., Shear, K., & Wittchen, H. (2008). Epidemiology of
Anxiety Disorders. In M.M. Anthony & M.B. Stein (Eds.). Oxford Handbook of
Anxiety and Related Disorders. Oxford: University Press.
Kessler, R.C., Sonnega, A., Bromet, E., Hughes, M., & Nelson, C.B. (1995).
Posttraumatic stress disorder in the national comorbidity study. Archives of General
Psychiatry, 52, 1048-1060.
Killeen, T., Hien, D., Campbell, A., Brown, C., Hansen, C., Jiang, H., Kristman-Valente,
A., Neuenfeldt, C., Rocz-de la Luz, N., Sampson, R., Suarez-Morales, L., Wells, E.,
Brigham, G., & Nunes, E. (2008). Adverse events in an integrated trauma-focused
intervention for women in community substance abuse treatment. Journal ofSubstance
Abuse Treatment, 35, 304-311.
126
Kimerling, R., Trafton, J.A., & Nguyen, B. (2006). Validation of a brief screen for
Post-Traumatic Stress Disorder with substance use disorder patients. Addictive
Behaviors, 31, 2074-2079.
Kingston, S. & Raghavan C. (2009). The Relationship of Sexual Abuse, Early Initiation
of Substance Use, and Adolescent Trauma to PTSD. Journal of Traumatic Stress, 22,
65-68.
Lang, A.J., Aarons, G.A., Gearity, J., Laffaye, C., Satz, L., Dresselhaus, T.R., & Stein,
M.B. (2008). Direct and indirect links between childhood maltreatment, posttraumatic
stress disorder, and women's health. Behavioral Medicine, 33, 125-135.
Makela, K. (2004). Studies of the reliability and validity of the Addiction Severity
Index. Addiction, 99, 398-410.
Marsden, J., Gossop, M., Stewart, D., Best, D., Farrell, M., Lehmann, P., Edwards, C., &
Strang, J. (1998). The Maudsley Addiction Profile (MAP): a brief instrument for
assessing treatment outcome. Addiction, 93, 1857-1868.
Mark, H.D., Nanda, J., Davis-Vogel, A., Navaline, H., Scotti, R., Wickrema, R.,
Metzger, D., & Sochalski, J. (2006). Profiles of Self-Reported HIV-Risk Behaviors
Among Injection Drug Users in Methadone Maintenance Treatment, Detoxification, and
Needle Exchange Programs. Public Health Nursing, 23, 11-19.
McFall, M.E., Mackay, P.W., & Donovan, D.M. (1992). Combat-related posttraumatic
stress disorder. Journal ofTraumatic Stress, 72,501-517.
McKetin, R., Kelly, E., McLaren, J., & Proudfoot, H. (2008). Impaired physical health
among methamphetamine users in comparison with the general population: The role of
methamphetamine dependence and opioid use. Drug andAlcohol Review, 27, 482-489.
127
McLellan, A.T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati,
H., & Argeriou, M. (1992). The Fifth Edition of the Addiction Severity Index. Journal
ofSubstance Abuse Treatment, 9, 199-213.
Messman-Moore, T.L., & Long, P.J. (2003). The role of childhood sexual abuse
sequelae in the sexual revictimisation of women: An empirical review and theoretical
reformulation. ClinicalPsychology Review, 23, 537-571.
Miele, G.M., Carpenter, K.M., Cockerham, M.S., Trautman, K.D., Blaine, J., & Hasin,
D.S. (2000a). Substance Dependence Seventy Scale (SDSS): reliability and validity of
a clinician-administered interview for DSM-IV substance use disorders. Drug and
Alcohol Dependence, 59, 63-75.
Miele, G.M., Carpenter, K.M., Cockerham, M.S., Trautman, K.D., Blaine, J., & Hasin,
D.S. (2000b). Concurrent and predictive validity of the Substance Dependence Severity
Scale (SDSS). Drug andAlcohol Dependence, 59, 77-88.
Mills, K.L., Lynskey, M., Teesson, M., Ross, J., & Darke, S. (2005). Post-traumatic
stress disorder among people with heroin dependence in the Australian treatment
outcome study (ATOS): prevalence and correlates. Drug and Alcohol Dependence, 77,
243-249.
Mills, K.L., Teeson, M., Ross, J., & Darke, S. (2007). The impact of post-traumatic
stress disorder on treatment outcomes for heroin dependence. Addiction, 102, 447-454.
Moos, R.H. (1988). Life Stressors and Social Resources Inventory (LISRES-Adult).
Odessa, FL: Psychological Assessment Resources.
128
Morrissey, J.P., Ellis, A.R., Gatz, M., Amaro, H., Reed, B.G., Savage, A., Finkelstein,
N., Mazelis, R., Brown, V., Jackson, E.W., & Banks, S. (2005). Outcomes for women
with co-occuring disorders and trauma: Program and person-level effects. Journal of
Substance Abuse Treatment, 28, 121-133.
Najavits, L.M. (2002). Seeking Safety: A Treatment Manual for PTSD and Substance
Abuse. New York: Guilford Press.
Najavits L.M., Gallop R.J., & Weiss R.D. (2006). Seeking Safety therapy for adolescent
girls with PTSD and substance abuse: A randomized controlled trial. Journal of
Behavioral Health Services & Research, 33, 453-463.
Najavits, L.M., Schmitz, M., Gotthardt, S., & Weiss, R.D. (2005). Seeking Safety plus
Exposure Therapy for Dual Diagnosis Men. Journal ofPsychoactive Drugs, 27, 425-
435.
Najavits, L.M., Ryngala, D., Back, S.E., Bolton, E., Muesser, K.T., & Brady, K.T.
(2009). Treatment of PTSD and Comorbid Disorders. In E. Foa, T.M. Keane, M.J.
Friedman & J.A. Cohen (Eds.). Effective Treatments for PTSD: Second Edition. New
York: Guilford Press.
Najavits, L.M., Sonn, J., Walsh, M., & Weiss, R.D. (2004). Domestic violence in
women with PTSD and substance abuse. Addictive Behaviors, 29, 707-715.
National Institute for Clinical Excellence. (2005). Clinical Guideline 26: Post¬
traumatic stress disorder (PTSD). The management ofPTSD in adults and children in
primary and secondary care. London: NICE.
129
Norman, SB., Tate, S.R., Anderson, K.G., & Brown, S.A. (2007). Do trauma history
and PTSD symptoms influence addiction relapse context? Drug and Alcohol
Dependence, 90, 89-96.
Nyamathi, A.M., Stein, J.A., & Bayley, L.J. (2000). Predictors of mental distress and
poor physical health among homeless women. Psychology and Health, 15, 483-500.
Ouimette, P C., Ahrens, C., Moos, RH., & Finney, J.W. (1997). Posttraumatic Stress
Disorder in Substance Abuse Patients: Relationship to 1-Year Posttreatment Outcomes.
Psychology ofAddictive Behaviors, 11, 34-47.
Ouimette, P., Coolhart, D., Funderburk, J.S., Wade, M., & Brown, P. (2007).
Precipitants of first substance use in recently abstinent substance use disorder patients
with PTSD. Addictive Behaviors, 32, 1719-1727.
Ouimette, P., Goodwin, E., & Brown, P.J. (2006). Flealth and well being of substance
use disorder patients with and without posttraumatic stress disorder. Addictive
Behaviors, 31, 1415-1423.
Ouimette, P., Moos, R.H., & Finney, J.W. (2003). PTSD Treatment and 5-Year
Remission Among Patients With Substance Use and Posttraumatic Stress Disorders.
Journal ofConsulting and Clinical Psychology, 71, 410-414.
Palacios, W.R, Urmann, C.F., Newel, R., & Hamilton, N. (1999). Journal ofSubstance
Abuse Treatment, 17, 91-102.
Parrott, D.J., Drobes, D.J., Saladin, M.E., Coffey, S.F., & Danksy, B. (2003).
Perpetration of partner violence: Effects of cocaine and alcohol dependence and
posttraumatic stress disorder. Addictive Behaviors, 28, 1587-1602.
130
Petkus, A.J., Gum, A.M., King-Kallimanis, B., & Wetherell, J.L. (2009). Trauma
history is associated with psychological distress and somatic symptoms in homebound
older adults. The American JournalofGeriatric Psychiatry, 17, 810-818.
Pirard, S., Sharon, E., Kang, S.K., Anganta, G.A., & Gastfriend, D.R. (2005).
Prevalence of physical and sexual abuse among substance abuse patients and impact on
treatment outcomes. Drug andAlcohol Dependence, 75,57-64.
Plotzker, R.E., Metzger, D.S., & Holmes, W.C. (2007). Childhood sexual and physical
abuse histories, PTSD, depression, and HIV risk outcomes in women injection drug
users: A potential mediating pathway. The American Journal on Addictions, 16, 431 -
438.
Raistrick, D., Bradshaw, J., Tober, G., Weiner, J., Allison, J., & Healey, C. (1994).
Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to
measure alcohol and opiate dependence in the context of a treatment evaluation package.
Addiction, 89, 563-572.
Rash, C.J., Coffey, S.F., Baschnagel, J.S., Drobes, D.J., & Saladin, M.E. (2008).
Psychometric properties of the IES-R in traumatized substance dependent individuals
with and without PTSD. Addictive Behaviors, 33, 1039-1047.
Rauch, & Foa, E.B. (2006). Emotional Processing Theory (EPT) and Exposure
Therapy for PTSD. Journal ofContemporary Psychotherapy, 36, 61-65.
Read, J.P., Bollinger, A.R., & Sharkansky, E. (2003). Assessment of Comorbid
Substance Use Disorder and Posttraumatic Stress Disorder. In P. Ouimette & P.J.
Brown, (Eds.). Trauma and Substance Abuse: Causes, Consequences, and Treatment of
Comorbid Disorders. Washington, DC: American Psychological Association.
131
Read, J.P., Brown, P.J., & Kahler, C.W. (2004). Substance use and posttraumatic stress
disorders: Symptom interplay and effects on outcome. Addictive Behaviors, 29, 1665-
1672.
Reed, P.L., Anthony, J.C., & Breslau, N. (2007). Incidence ofDrug Problems in Young
Adults Exposed to Trauma and Posttraumatic Stress Disorder. Archives of General
Psychiatry, 64, 1435-1442.
Reynolds, M., Mezey, G., Chapman, M., Wheeler, M., Drummond, C., & Baldacchino,
A. (2005). Co-morbid post-traumatic stress disorder in a substance misusing clinical
population. Drug andAlcoholDependence, 77, 251-258.
Roxburgh, A., Degenhardt, L., & Copeland, J. (2006). Posttraumatic stress disorder
among female street-based sex workers in the greater Sydney area, Australia. BMC
Psychiatry, 6,24.
Saladin, M.E., Brady, K.T., Dansky, B.S., & Kilpatrick, D.G. (1995). Understanding
comorbidity between PTSD and substance user disorders: Two preliminary
investigations. Addictive Behaviors, 20, 643-655.
Schafer, I. & Najavits, L.M. (2007). Clinical challenges in the treatment of patients
with posttraumatic stress disorder and substance misuse. Current Opinion in Psychiatry,
20, 614-618.
Schiff, M., El-Bassel, N., Engstrom, M., & Gilbert, L. (2002). Psychological Distress
and Intimate Physical and Sexual Abuse among Women in Methadone Maintenance
Treatment Programs. Social Service Review, 76,302-320.
Scottish Government (2008). The Road to Recovery: A New Approach to Tackling
Scotland's Drug Problem. Edinburgh: Author.
132
Scottish Government (2007). Mental Health in Scotland: Closing the Gaps - Making a
Difference: Commitment 13. Edinburgh: Author.
Sharkansky, E.J., Brief, D.J., Peirce, J.M., Meehan, J.C., & Mannix, L.M. (1999).
Substance Abuse Patients With Posttraumatic Stress Disorder (PTSD): Identifying
Specific Triggers of Substance Use and Their Associations With PTSD Symptoms.
Psychology ofAddictive Behaviors, 13, 89-97.
Somer, E. (2003). Prediction of abstinence from heroin addiction by childhood trauma,
dissociation, and extent of psychosocial treatment. Addiction Research and Theory, 11,
339-348.
Spielberger, C. D., Gorsuch, R.L., & Lushene. R.E. (1970). Manualfor the State-Trait
Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
Spitzer, R.L., Williams, J.B.W., Gibbon, M., & First, M.B. (1990). Structured Clinical
Interview for DSM-III-R-Patient ed., (With Psychotic Screen; SCID-P). Washington,
DC: American Psychiatric Press.
Spooner, C., Bishop, J., & Parr, J. (1997). Research methods for studying injecting
drug users in a rural centre. Drug andAlcohol Review, 16, 349-355.
Stein, M.B., McQuaid, J.R., Pedrelli, P., Lenox, R., & McCahill, M.E. (2000).
Posttraumatic Stress Disorder in the Primary Care Medical Setting. General Hospital
Psychiatry, 22, 261-269.
Stewart, S.H. & Conrod, P.J. (2003). Psychosocial Models of Functional Associations
between Posttraumatic Stress Disorder and Substance Use Disorder. In P. Ouimette &
P.J. Brown, (Eds). Trauma and Substance Abuse: Causes, Consequences, and
133
Treatment of Comorbid Disorders. Washington, DC: American Psychological
Association.
Stewart, S.H, Conrod, P.J., Pihl, R.O., & Dongier, M. (1999). Relationships between
posttraumatic stress symptom dimensions and substance dependence in a community-
recruited sample of substance-abusing women. Psychology ofAddictive Behaviours, 13,
78-88.
Stewart, S.H., Pihl, R.O., Conrod, P.J., & Dongier, M. (1998). Functional associations
among trauma, PTSD, and substance-related disorders. Addictive Behaviors, 23, 797-
812.
Straus, M.A., Hamby, S.L., Boney McCoy, S., & Sugarman, D.B. (1996). The revised
Conflict Tactics Scales (CTS2): Development and preliminary psychometric data.
Journal ofFamily Issues, 17, 283-316.
Struening, E. & Padgett, D. (1990). Physical health status, substance use and abuse,
and mental disorders among homeless adults. Journal ofSocial Issues, 46, 65-81.
Tate, S.R., Norman, S B., McQuaid, J.R., & Brown, S.A. (2007). Health problems of
substance-dependent veterans with and those without trauma history. Journal of
SubstanceAbuse Treatment, 33, 25-32.
Thompson, M.P., & Kingree, J.B. (1998). The frequency and impact of violent trauma
among pregnant substance abusers. Addictive Behaviors, 23, 257-262.
Ullman, S.E., Filipas, H.H., Townsend, S.M., & Starzynski, L.L. (2006). Correlates of
comorbid PTSD and drinking problems among sexual assault survivors. Addictive
Behaviors, 31, 128-132.
134
Ullman, S.E., Townsend, S.M., Starzynski, L.L., & Long, L.M. (2006). Correlates of
Comorbid PTSD and Polysubstance Use in Sexual Assault Victims. Violence and
Victims, 21, 725-743.
van der Kolk, B. A. (1996). Traumatic Stress: The Effects ofOverwhelming Experience
on Mind, Body and Society. London: Guilford Press.
van Dorn, R.A., Mustillo, S., Elbogen, E.B., Dorsey, S., Swanson, J.W., & Swartz, M.S.
(2005). The effects of early sexual abuse on adult risky sexual behaviors among persons
with severe mental illness. ChildAbuse & Neglect, 29, 1265-1279.
Wasserman, D.A., Havassy, B.E., & Boles, S.M. (1997). Traumatic events and post¬
traumatic stress disorder in cocaine users entering private treatment. Drug and Alcohol
Dependence, 46, 1-8.
Weathers, F.W., Litz, B.T., Herman, D.S., Huska, J.A., & Keane, T.M. (1993, October).
The PTSD Checklist (PCL): Reliability, validity and diagnostic utility. Poster presented
at the 9th annual meeting of the International Society for Traumatic Stress Studies, San
Antonio, TX.
Weathers, F.W., Litz, B.T., Huska, J.A., & Keane, T.M. (1994). PTSD Checklist -
Civilian version. Boston National Center for PTSD, Behavioral Sciences Division.
Weiss, D.W. 8c Marmar, C.R. (1997). The Impact of Event Scale - Revised. In J.P.
Wilson & T.S. Keane, (Eds). Assessing Psychological Trauma and PTSD: A Handbook
for Practitioners. New York: Guildford.
Weissbecker, I. & Clark, C. (2007). The impact of violence and abuse on women's
physical health: Can trauma-informed treatment make a difference? Journal of
Community Psychology, 35, 909-923.
135
Williamson, A., Darke, S., Ross, J., & Teesson, M. (2009). Changes and predictors of
change in the physical health status of heroin users over 24 months. British Journal of
Addiction, 104, 465-470.
Wohlfarth, T.D., van den Brink, W., Winkel, F.W., & ter Smitten, M. (2003).
Screening for Posttraumatic Stress Disorder: An Evaluation of Two Self-Report Scales
Among Crime Victims. PsychologicalAssessment, 15, 101-109.
World Health Organisation (1992). International Statistical Classification ofDiseases
and RelatedHealth Problems 10th Revision (ICD-10). Geneva: WHO.




Appendix 1 Letter ofEthical Approval i
Appendix 2 Letter ofResearch & Development Approval V
Appendix 3 Participant Information Leaflet vii
Appendix 4 Consent Form ix
Appendix 5 Maudsley Addiction Profile (MAP) X
Appendix 6 Response Card for Measures xiv
Appendix 7 Leeds Dependence Questionnaire (LDQ) xvi
Appendix 8 Posttraumatic Stress Diagnostic Scale (PDS) xvii
Appendix 9 DSM-IV Criteria for Posttraumatic Stress Disorder xxi






Telephone 01 31 536 9000




Lothian Local Research Ethics Committee 02
Telephone: 0131 536 9061
Facsimile: 0131 536 9346
25 June 2007
Ms Penny J Leeming
Trainee Clinical Psychologist
University of Edinburgh





Full title of study: Prevalence of Post-Traumatic Stress Disorder (PTSD) in a
Community Sample of Injecting Drug Users.
REC reference number: 07/S1102/17
Thank you for your letter of 06 June 2007, responding to the Committee's request for further
information on the above research and submitting revised documentation.
The further information was considered at the meeting of the Sub-Committee of the REC
held on 25 June 2007.
Confirmation of ethical opinion
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the
above research on the basis described in the application form, protocol and supporting
documentation as revised.
Conditions of approval
The favourable opinion is given provided that you comply with the conditions set out in the
attached document. You are advised to study the conditions carefully.
Approved documents
The final list of documents reviewed and approved by the Committee is as follows:
Document Version Date
Application 5.3 06 June 2007
Application 21 March 2007
Investigator CV 21 March 2007
Protocol 2 12 April 2006
Letter from Sponsor 01 February 2007
Questionnaire: The Leeds Dependance Questionnaire Validated
Questionnaire: Maudsley Addication Profile (MAP) Validated
^ue'ltionnaii^PosttuffliitEtic Stress Diagnostic Scale
l. ~ a /I/a' (K.'ail -
Validated
XC o 1/4 / -7
-.y%t Csear
INVESTOR IN PEOPLE




Participant Information Sheet: Participant 2 02 May 2007
Participant Information Sheet 1 21 March 2007
Participant Consent Form 1 21 March 2007
Response to Request for Further Information 06 June 2007
Insurance Details 28 July 2007
Supervisor CV 21 March 2007
R&D approval
All researchers and research collaborators who will be participating in the research at NHS
sites should apply for R&D approval from the relevant care organisation, if they have not yet
done so. R&D approval is required, whether or not the study is exempt from SSA. You
should advise researchers and local collaborators accordingly.
Guidance on applying for R&D approval is available from
http://www.rdforum.nhs.uk/rdform.htm.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for
Research Ethics Committees (July 2001) and complies fully with the Standard Operating
Procedures for Research Ethics Committees in the UK.
Feedback on the application process
Now that you have completed the application process you are invited to give your view of
the service you received from the National Research Ethics Service. If you wish to make
your views known please use the feedback form available on the NRES website at:
https://www.nresform.org.uk/AppForm/Modules/Feedback/EthicalReview.aspx
We value your views and comments and will use them to inform the operational
process and further improve our service.
07/S1102/17 Please quote this number on all
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Letter of Research & Development Approval
University Hospitals Division
Queen's Medical Research Institute





















Prevalence of Post - Traumatic Stress Disorder (PTSD) in
community sample of injecting drug users.
NHS
Protocol No/Acronym: N/A
The above project has undergone an assessment of risk to NHS Lothian and review of resource
and financial implications. I am satisfied that all the necessary arrangements have been set in
place and that all Departments contributing to the project have been informed.
I note that this is a single centre study sponsored by University of Edinburgh.
On behalf of the Chief Executive and Medical Director, I am happy to grant management
approval from NHS Lothian to allow the project to commence, subject to the approval of the
appropriate Research Ethics Committee(s) having also been obtained. You should note that any
substantial amendments must be notified to the relevant Research Ethics Committee and to
R&D Management with approval being granted from both before the amendments are made.
Please note that under Section A, Q35, NHS Lothian provides indemnity for negligence for NHS
and Honorary clinical staff for research associated with their clinical duties. It is not empowered
to provide non-negligent indemnity cover for patients. NHS Lothian does not provide indemnity
against negligence for healthy volunteer studies. This is the personal responsibility of both NHS
and honorary employees and is usually arranged with a medical defence organisation or
through the University of Edinburgh.
This letter of approval is your assurance that NHS Lothian is satisfied with your study. As Chief
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Professor Heather A Cubie
R&D Governance Manager:
Dr Tina McLelland


























St John's - Administrator:
Mrs Anne Addison
"Improving health through excellence and innovation in clinical research"
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Letter of Research & Development Approval Appendix 2
within the Research Governance Framework for Health and Community Care, an extract of which
attached to this letter.
Yours sincerely
Professor Heather A Cubie
R&D Director
Enc Research Governance Certificate
NRR authorisation
Tissue Policy (if applicable)
MTA (if applicable)
5/ (to be signed and returned)
cLfto be signed and returned)
□
□ (to be signed and returned by the recipient of
Tissue)
Copies Administrators, Research Ethics Committee
"Improving health through excellence and innovation in clinical research"
Participant Information Sheet Appendix 3
Participant Information Sheet
Study title
Prevalence of Post-Traumatic Stress Disorder (PTSD) in a Community Sample of
Injecting Drug Users.
You are being invited to take part in a research study. Before you decide it is
important to understand why the research is being done and what it will involve.
Please take time to read the following information carefully and discuss it with
others if you wish. Ask us if there is anything that is not clear or if you would like
more information. Take time to decide whether or not you wish to take part.
Thank you for reading this.
What is the purpose of the study?
This study aims to look at the number of injecting drug users in treatment in
Lothian who also have Post-traumatic Stress Disorder (PTSD). PTSD is an
anxiety disorder that can develop after experiencing a terrifying event or ordeal.
.«
The research will form part of the researcher's work for her Doctorate in Clinical
Psychology degree.
Why have I been chosen?
You have been chosen as you are currently being seen by the Harm Reduction
Team or the Community Drug Problem Service (CDPS). '
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part
you will be given this information sheet to keep and be asked to sign a consent
form. If you decide to take part you are still free to withdraw at any time and
without giving a reason. A decision to withdraw at any time, or a decision not to
take part, will not affect the standard of care you receive.
What will happen to me if I take part?
If you agree to take part you will be asked to sign a consent form which you will
be given to keep with this information sheet. A copy of the consent form will be
kept by the researcher.
vii
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If you decide to take part you will meet up with the researcher in the clinic you
attend. The researcher will complete three questionnaires with you which will
take about 35 minutes.
Some people may find some of the questions upsetting. If this happens you can
decide not to answer these questions and you will be able to talk to someone
about how you are feeling. Your medical care will not be affected by your
decision not to answer the questions. There will also be an opportunity at end of
the meeting to discuss any issues related to the meeting with the researcher. If it
is found that you have Post-traumatic Stress Disorder, available forms of support
will be discussed with you.
Will my taking part in this study be kept confidential?
All information which is collected about you during the course of the research will
be kept strictly confidential. Any information about you which leaves the clinic
will have your name and address removed so that you cannot be recognised
from it.
What will happen to the results of the research study?
Findings from the study will be presented in a written report to Edinburgh
University as coursework for the Doctorate in Clinical Psychology degree.
It may be possible in the future for this report to be published in academic
journals or presented at conferences. Participants' names will not be used in any
part of the research and the service they attended will not be identified.
If you would like a copy of the results, these can be obtained from the
researcher.
Who is organising and funding the research?
This research is part of the coursework for the Doctorate in Clinical Psychology
degree at the University of Edinburgh. The researcher is not being paid and
expenses are not available for anyone participating in the study.
Who has reviewed the study?
The study has been reviewed by the Lothian Local Research Ethics Committee
and the Course Organisation Group of the East of Scotland Clinical Psychology
Course:
Contact for further information
For further information please contact the researcher: Penny Leeming, Trainee
Clinical Psychologist, Spittal Street Centre on 0131 537 8300.
Thank you for taking time to read this information leaflet.
viii
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CONSENT FORM
Title of Study
Prevalence ofPost-Traumatic Stress Disorder (PTSD) in a Community
Sample of Injecting Drug Users and a Pilot Intervention for Injecting Drug
Users with Co-occurring PTSD.
Name of Researcher: Penny Leeming, Trainee Clinical Psychologist
Please initial box
1. I confirm that I have read and understand the information sheet for the
above study and have had the opportunity to ask questions.
2. I understand that my participation is voluntary and that I am free to
withdraw at any time, without giving any reason, without my medical
care or legal rights being affected.
3. I agree to take part in the above study.
Name of Participant Date Signature
Name of Person taking consent Date Signature
(if different from researcher)
Researcher Date Signature





MAUDSLEY ADDICTION PROFILE (MAP)
SECTION A: MANAGEMENT INFORMATION
Include the study specific information as required (e.g. participant identification, programme codes; interview point)
SECTION B: SUBSTANCE USE
CARD 1
None 1 day 2 days 3 days 1 day a 2 days 3 days 4 days 5 days 6 days Every Some
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a. Enter nu ber of days used in past 30 days [Card 1] - enter "0" for no use
b. Enter amount used on a typical day in the past 30 days [verbatim]
c. Record route(s) of administration [Card 2]
7- " | M
SUBSTANCE
B1. Alcohol












Maudslev Addiction Profile Appendix 5
SECTION C: HEALTH RISK BEHAVIOUR
If no illicit drugs injected in the past 30 days, skip to sexual behaviour questions
C1. Days injected drugs in the past 30 davs fcard 11 Days
C2. Times injected on a typical day in the past 30 days ftT Times
C3. Times injected with a needle/syringe already used by someone else Times
II gp
If no penetrative sex in the past 30 days, skip to Section D
C4. Number of people had sex with and not used condom People
C5. Total number of times had sex with and not used condom Times
SECTION D: HEALTH SYMPTOMS
CARD 3
Never Rarely Sometimes Often Always
0 12 3 4
D1. How often experienced the following physical health symptoms
Never Rarely Sometimes 1 Often Always
(0) (1) (2) (3) (4)
a. PooraoDetite □ □ □ □ □
b. Tiredness/fatique □ □ □ □ □
c. Nausea (feeling sick) □ □ □ n □
d. Stomach oains n □ □ □ □
e. Difficulty breathinq □ □ □ □ □
f. Chest pains □ □ □ □ □
q. Joint/bone pains □ □ □ □ □
h. Muscle pains □ □ n □ □
i. Numbness/tinclina □ □ □ □ n
i. Tremors/shakes n n □ □ □
38
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D2. How often experienced the following emotional or psychological symptoms [card 3]
Never Rarely Sometimes Often Always
(0) (1) (2) (3) (4)
a. Feeling tense □ □ □ □ □
b. Suddenly scared for no reason □ □ □ □ □
c. Feeling fearful n □ n □ □
d. Nervousness of shakiness inside n □ □ .□ □
e. Spells of terror or panic □ □ □ □ □
f. Feeling hopeless about the future □ □ □ □ □
g. Feelings of worthlessness □ □ n □ □
h. Feeling no interest in things □ □ □ □ □
i. Feeling lonelv □ □ □ □ □
i. Thoughts of ending vour life □ □ □ □ □
SECTION E: PERSONAL/SOCIAL FUNCTIONING
If not in a relationship in the past 30 days, skip to relatives questions
E1. Davs had contact with partner in the past 30 days [card 1]
(ie. say them or talked on the telephone)
Days
E2. Number of these davs were there was conflict with partner
(ie. had major arguments)
Days
mm ■vote-.-■
If not relatives or any contact with relatives in past 30 days, skip to friends questions
E3. Days had contact with relatives in the past 30 days [card 1]
(ie. say them or talked on the telephone)
Days
- "**.> J' *
E4. Number of these davs were there was conflict with relatives
(ie. had major arguments)
Days
lg§jgg|
If not friends or any contact with friends in past 30 days, skip to Section E7
E5. Davs had contact with friends in the past 30 days [card 1 ] Days
(ie. say them or talked on the telephone)
E6. Number of these davs were there was conflict with friends




Maudsley Addiction Profile Appendix 5
E7. Number of days of paid work in past 30 days [card 1] Days
E8. Days missed from work because of sickness or unauthorised absence
in the past 30 days
Days



















committed on a typical
day [card 2]
sirySiiiH i
m ~ - w if
d. Theft from a property
e. Theft from a vehicle
f. Theft of a vehicle
Other crimes:
lyiiMftfe





Response Cards Appendix i
Card 1 Card 4
Every day 30 Selling drugs
6 days a week 26 Fraud/forgery
5 days a week 21 Theft from a property
4 days a week 17 Theft from a person
3 days a week 13 Shoplifting
2 days a week 9 Theft from a vehicle
Seven days 7 Theft of a vehicle









Not at all or only one time
Once a week or less/once in a while
2 to 4 times a week/half the time







OralSno t/sniffSm ke/chaseI trave ousIntr musc lar Card3 NeverRar lySometimesOft nAlways 01234 Never 0CardA(LDQ) SometimesOften 12
Nearlyalways 3
Leeds Dependence Questionnaire Appendix 7
The Leeds Dependence Questionnaire
On this page there are questions about the importance of alcohol and/or other drugs in your
life.
Think about your drinking/other drug use in the last week and answer each question ticking
the closest answer to how you see yourself.
Never Sometimes Often Nearly always
1. Do you find yourself thinking about
when you will next be able to have
another drink or take more drugs?
2. Is drinking or taking drugs more
important than anything else you
might do during the day?
3. Do you feel that your need for drink
or drugs is too strong to control?
4. Do you plan your days around
getting and taking drink or drugs?
5. Do you drink or take drugs in a
particular way in order to increase the
effect it gives you?
6. Do you take drink or other drugs
morning, afternoon and evening?
7. Do you feel you have to carry on
drinking or taking drugs once you
have started?
8. Is getting the effect you want more
important than the particular drink or
drug you use?
9. Do you want to take more drink or




10. Do you find it difficult to cope with
life without drink or drugs?
xvi
Posttraumatic Stress Diagnostic Scale Appendix 8 .
This booklet contains 49 items. Use the separate answer sheet to record your responses to the items. For
each numbered item, find the corresponding number on your answer sheet and fill in the circle that matches
your answer. Use a pencil and fill in the circles on the answer sheet with a fieavy, dark mark. Do not make any
marks outside the circles. If you want to change an answer, erase it carefully and then fill in your new choice.
Do not make any marks in this booklet.
As you mark each answer, be sure that the item number in the test booklet matches the item number on the
answer sheet.
PART 1
Many people have lived through or witnessed a very stressful and traumatic event at some point in their lives.
Indicate whether or not you have experienced or witnessed each traumatic event listed below by marking
® for Yes or® for No on the answer sheet.
1. Serious accident, fire, or explosion (for
example, an industrial, farm, car, plane, or
boating accident)
2. Natural disaster (for example, tornado,
hurricane, flood, or major earthquake)
3. Non-sexual assault by a family member or
someone you know (for example, being
mugged, physically attacked, shot, stabbed, or
held at gunpoint)
4. Non-sexual assault by a stranger (for example,
being mugged, physically attacked, shot,
stabbed, or held at gunpoint)
5. Sexual assault by a family member or
someone you know (for example, rape or
attempted rape)
6. Sexual assault by a stranger (for example,
rape or attempted rape)
7. Military combat or a war zone
8. Sexual contact when you were younger than
18 with someone who was 5 or more years
older than you (for example, contact with
genitals, breasts)
9. Imprisonment (for example, prison inmate,
prisoner of war, hostage)
10. Torture ,
11. Life-threatening illness
12. Other traumatic event
13. If you answered Yes to Item 12, specify the
traumatic event on the answer sheet.
IF YOU MARKED YES TO ANY OF THE ITEMS
ABOVE, CONTINUE. IF NOT, STOP HERE,
Go on to the next page,
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PART 3
Below is a list of problems that people sometimes have after experiencing a traumatic event. Read each one
carefully and choose the answer (0-3) that best describes how often that problem has bothered you IN THE
PAST MONTH. Rate each problem with respect to the traumatic event you marked in Item 14.
® Not at all or only one time
© Once a week or less/once in a while
© 2 to 4 times a week/half the time
© 5 or more times a week/almost always
22. Having upsetting thoughts or images about
the traumatic event that came into your head
when you didn't want them to
23. Having bad dreams or nightmares about the
traumatic event
24. Reliving the traumatic event, acting or feeling
as if it was happening again
25. Feeling emotionally upset when you were
reminded of the traumatic event (for example,
feeling scared, angry, sad, guilty, etc.)
26. Experiencing physical reactions when you
were reminded of the traumatic event (for
example, breaking out in a sweat, heart
beating fast)
27. Trying not to think about, talk about, or have
feelings about the traumatic event
28. Trying to avoid activities, people, or places
that remind you of the traumatic event
29. Not being able to remember an important part
of the traumatic event
30. Having much less interest or participating
much less often in important activities
31. Feeling distant or cut off from people around
you
32. Feeling emotionally numb (for example, being
unable to cry or unable to have loving feelings)
33. Feeling as if your future plans or hopes will
not come true (for example, you will not have
a career, marriage, children, or a long life)
34. Having trouble falling or staying asleep
35. Feeling irritable or having fits of anger
36. Having trouble concentrating (for example,
drifting in and out of conversations, losing
track of a story on television, forgetting what
you read)
37. Being overly alert (for example, checking to
see who is around you, being uncomfortable
with your back to a door, etc.)
38. Being jumpy or easily startled (for example,
when someone walks up behind you)
39. How long have you experienced the problems
that you reported above? (Mark only ONE on
the answer sheet.)
1. Less than 1 month
2. 1 to 3 months
,
3. More than 3 months
40. How long after the traumatic event did these
problems begin? (Mark only ONE on the
answer sheet.)
1. Less than 6 months
2. 6 or more months
Go on to the next page.
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PART 4
Indicate if the problems you rated in Part 3 have interfered with any of the following areas of your
life DURING THE PAST MONTH. Mark ® for Yes or ® for No on the answer sheet.
41. Work
42. Household chores and duties
43. Relationships with friends
44. Fun and leisure activities
45. Schoolwork
46. Relationships with your family
47. Sex life
48. General satisfaction with life
49. Overall level of functioning in all areas of your
life
xx
DSM-IV Criteria for Posttraumatic Stress Disorder Appendix 9
V
Diagnostic Criteria for Posttraumatic Stress Disorder
A. The person has been exposed to a traumatic event in which both of the
following were present:
1) The person experienced, witnessed, or was confronted with an event or events
that involved actual or threatened death or serious injury, or a threat to the
physical integrity of self or others.
2) The person's response involved intense fear, helplessness, or horror. Note: In
children, this may be expressed instead by disorganized or agitated behavior.
B. The traumatic event is persistently reexperienced in one (or more) of the
following ways:
1) Recurrent and intrusive distressing recollections of the event, including images,
thoughts, or perceptions. Note: In young children, repetitive play may occur in
which themes or aspects of the trauma are expressed.
2) Recurrent distressing dreams of the event. Note: In children, there may be
.«
frightening dreams without recognizable content.
3) Acting or feeling as if the traumatic event were recurring (includes a sense of
reliving the experience, illusions, hallucinations, and dissociative flashback
episodes, including those that occur on awakening or when intoxicated). Note: In
*
young children, trauma-specific reenactment may occur. ,
4) Intense psychological distress at exposure to internal or external cues that
symbolize or resemble an aspect of the traumatic event.
5) Physiological reactivity on exposure to internal or external cues that symbolize or
resemble an aspect of the traumatic event.
C. Persistent avoidance of stimuli associated with the trauma and numbing of
general responsiveness (not present before the trauma), as indicated by three (or
more) of the following:
1) Efforts to avoid thoughts, feelings, or conversations associated with the trauma;
xxi
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2) Efforts to avoid activities, places, or people that arouse recollections of the
trauma;
3) Inability to recall an important aspect of the trauma;
4) Markedly diminished interest or participation in significant activities;
5) Feeling of detachment or estrangement from others;
6) Restricted range of affect (e.g., unable to have loving feelings);
7) Sense of a foreshortened future (e.g., does not expect to have a career,
marriage, children, or a normal life span).
D. Persistent symptoms of increased arousal (not present before the trauma), as
indicated by two (or more) of the following:
1) Difficulty falling or staying asleep;
2) Irritability or outbursts of anger;
3) Difficulty concentrating;
4) Hypervigilance;
5) Exaggerated startle response.
E. Duration of the disturbance (symptoms in Criteria B, C, and D) is more than 1
month.
F. The disturbance causes clinically significant distress or impairment in social,
occupational, or other important areas of functioning.
Specify if:
Acute: if duration of symptoms is less than 3 months.
Chronic: if duration of symptoms is 3 months or more.
Specify if:
With Delayed Onset: if onset of symptoms is at least 6 months after the stressor.
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